Unnamed: 0 stringlengths 3 8 | Date stringlengths 23 23 | Article_title stringlengths 1 250 | Stock_symbol stringlengths 1 5 | Url stringlengths 44 135 | Publisher stringclasses 1
value | Author stringclasses 1
value | Article stringlengths 1 343k | Lsa_summary stringlengths 3 53.9k | Luhn_summary stringlengths 1 53.9k | Textrank_summary stringlengths 1 53.9k | Lexrank_summary stringlengths 1 53.9k |
|---|---|---|---|---|---|---|---|---|---|---|---|
38500.0 | 2019-04-17 00:00:00 UTC | Why 1 Analyst Just Slashed Revenue Estimates for Canopy Growth -- and What It Could Mean for Other Marijuana Stocks | ACB | https://www.nasdaq.com/articles/why-1-analyst-just-slashed-revenue-estimates-canopy-growth-and-what-it-could-mean-other | nan | nan | Canopy Growth (NYSE: CGC) enjoyed its best quarter in the company's history when the Canadian marijuana producer reported its third-quarter results in February. Revenue soared 256% -- not from the prior-year period but from the previous quarter. Canopy even posted a nice profit, although this achievement was only made ... | All of these factors affect Canopy Growth's top rivals, including Aurora Cannabis (NYSE: ACB), Aphria (NYSE: APHA), Cronos Group (NASDAQ: CRON), and Tilray (NASDAQ: TLRY). Canopy Growth (NYSE: CGC) enjoyed its best quarter in the company's history when the Canadian marijuana producer reported its third-quarter results ... | All of these factors affect Canopy Growth's top rivals, including Aurora Cannabis (NYSE: ACB), Aphria (NYSE: APHA), Cronos Group (NASDAQ: CRON), and Tilray (NASDAQ: TLRY). Teething pains Scotiabank now expects Canopy Growth will report Q4 revenue of 87 million in Canadian dollars, 26% less than its previous revenue est... | All of these factors affect Canopy Growth's top rivals, including Aurora Cannabis (NYSE: ACB), Aphria (NYSE: APHA), Cronos Group (NASDAQ: CRON), and Tilray (NASDAQ: TLRY). Canopy Growth (NYSE: CGC) enjoyed its best quarter in the company's history when the Canadian marijuana producer reported its third-quarter results ... | All of these factors affect Canopy Growth's top rivals, including Aurora Cannabis (NYSE: ACB), Aphria (NYSE: APHA), Cronos Group (NASDAQ: CRON), and Tilray (NASDAQ: TLRY). Here's why -- and what it could mean for Canopy and other Canadian marijuana stocks. Teething pains Scotiabank now expects Canopy Growth will report... |
38501.0 | 2019-04-17 00:00:00 UTC | Pre-Market Most Active for Apr 17, 2019 : SFS, QCOM, NIO, UXIN, ERIC, INTC, ACB, NFLX, COLD, S, SQQQ, UN | ACB | https://www.nasdaq.com/articles/pre-market-most-active-apr-17-2019-sfs-qcom-nio-uxin-eric-intc-acb-nflx-cold-s-sqqq-un | nan | nan | The NASDAQ 100 Pre-Market Indicator is up 43.22 to 7,697.95. The total Pre-Market volume is currently 10,836,372 shares traded.
The following are the most active stocks for the pre-market session :
Smart ( SFS ) is +1.09 at $6.48, with 4,327,524 shares traded. SFS's current last sale is 108% of the target price of $6.
... | Aurora Cannabis Inc. ( ACB ) is +0.23 at $9.11, with 627,463 shares traded. ACB's current last sale is 103.7% of the target price of $8.785. The following are the most active stocks for the pre-market session : Smart ( SFS ) is +1.09 at $6.48, with 4,327,524 shares traded. | Aurora Cannabis Inc. ( ACB ) is +0.23 at $9.11, with 627,463 shares traded. ACB's current last sale is 103.7% of the target price of $8.785. NIO Inc. ( NIO ) is +0.2299 at $4.68, with 2,174,069 shares traded., following a 52-week high recorded in prior regular session. | Aurora Cannabis Inc. ( ACB ) is +0.23 at $9.11, with 627,463 shares traded. ACB's current last sale is 103.7% of the target price of $8.785. The total Pre-Market volume is currently 10,836,372 shares traded. | ACB's current last sale is 103.7% of the target price of $8.785. Aurora Cannabis Inc. ( ACB ) is +0.23 at $9.11, with 627,463 shares traded. The NASDAQ 100 Pre-Market Indicator is up 43.22 to 7,697.95. |
38502.0 | 2019-04-16 00:00:00 UTC | Aurora Cannabis To Acquire Remaining 48% Stake In Hempco Food And Fiber | ACB | https://www.nasdaq.com/articles/aurora-cannabis-acquire-remaining-48-stake-hempco-food-and-fiber-2019-04-17 | nan | nan | (RTTNews) - Canadian marijuana producer Aurora Cannabis Inc. (ACB, ACB.TO) has agreed to acquire the remaining 48 percent stake in Hempco Food and Fiber Inc. (HEMP.V) that it does not already own, in a deal that values Hempco at about C$63.4 million. Shares of Hempco gained more than 10 percent in Tuesday's trading.
Au... | (RTTNews) - Canadian marijuana producer Aurora Cannabis Inc. (ACB, ACB.TO) has agreed to acquire the remaining 48 percent stake in Hempco Food and Fiber Inc. (HEMP.V) that it does not already own, in a deal that values Hempco at about C$63.4 million. Following completion of the transaction, Hempco will provide Aurora w... | (RTTNews) - Canadian marijuana producer Aurora Cannabis Inc. (ACB, ACB.TO) has agreed to acquire the remaining 48 percent stake in Hempco Food and Fiber Inc. (HEMP.V) that it does not already own, in a deal that values Hempco at about C$63.4 million. Aurora noted that the deal will strengthen the execution of its globa... | (RTTNews) - Canadian marijuana producer Aurora Cannabis Inc. (ACB, ACB.TO) has agreed to acquire the remaining 48 percent stake in Hempco Food and Fiber Inc. (HEMP.V) that it does not already own, in a deal that values Hempco at about C$63.4 million. Under the terms of the deal, Aurora has agreed to pay C$1.04 per Hemp... | (RTTNews) - Canadian marijuana producer Aurora Cannabis Inc. (ACB, ACB.TO) has agreed to acquire the remaining 48 percent stake in Hempco Food and Fiber Inc. (HEMP.V) that it does not already own, in a deal that values Hempco at about C$63.4 million. Aurora noted that the deal will strengthen the execution of its globa... |
38503.0 | 2019-04-16 00:00:00 UTC | 3 Sin Stocks to Double Down On | ACB | https://www.nasdaq.com/articles/3-sin-stocks-to-double-down-on-2019-04-16 | nan | nan | While sin stocks are traditionally thought of as a recessionary hedge — in part, due to generous dividends paid by some — they can also serve as macro and special situation plays. History has shown that investing in casinos, alcohol beverage makers and cigarette manufacturers can net you a nice return.
This is especial... | Management has indicated that if they remain disciplined, they could “achieve sustained positive EBITDA beginning in fiscal Q4 2019 (calendar Q2 2019).” Finally, with all the M&A going on in the cannabis space, especially companies that are traded on the major U.S. exchanges, it would not be a surprise to see ACB get s... | Aurora Cannabis (ACB) Source: Shutterstock Aurora Cannabis (NYSE:) had a productive second quarter and the company continues to expand rapidly on the manufacturing front as well as management. ACB has been bulking up with senior management, especially on the strategy side. ACB has been seeing an uptick in demand with a... | Aurora Cannabis (ACB) Source: Shutterstock Aurora Cannabis (NYSE:) had a productive second quarter and the company continues to expand rapidly on the manufacturing front as well as management. ACB has been bulking up with senior management, especially on the strategy side. ACB has been seeing an uptick in demand with a... | Aurora Cannabis (ACB) Source: Shutterstock Aurora Cannabis (NYSE:) had a productive second quarter and the company continues to expand rapidly on the manufacturing front as well as management. ACB has been bulking up with senior management, especially on the strategy side. ACB has been seeing an uptick in demand with a... |
38504.0 | 2019-04-16 00:00:00 UTC | Aurora Cannabis Is on Pace for 780,000 Kilos a Year, With 1 Million a Real Possibility | ACB | https://www.nasdaq.com/articles/aurora-cannabis-pace-780000-kilos-year-1-million-real-possibility-2019-04-16 | nan | nan | At the moment, there's simply no industry growing faster, or garnering more attention from Wall Street and investors, than marijuana. Following the legalization of recreational weed in Canada, and now having over 40 countries worldwide with some sort of medical cannabis legalization in place, the sky appears to be the ... | Aurora Cannabis increases production at its largest grow farm by more than 50% Last week, my newest published production list once again became outdated, thanks to Aurora Cannabis (NYSE: ACB). Before this announcement, I'd detailed 700,000 kilos of peak annual production for the company, which assumed it would complete... | Aurora Cannabis increases production at its largest grow farm by more than 50% Last week, my newest published production list once again became outdated, thanks to Aurora Cannabis (NYSE: ACB). However, to support Aurora's push into overseas markets, Aurora is expanding the facility by 33% to 1.62 million square feet. K... | Aurora Cannabis increases production at its largest grow farm by more than 50% Last week, my newest published production list once again became outdated, thanks to Aurora Cannabis (NYSE: ACB). Keep in mind, though, Aurora tends to be conservative with its large grow farm production estimates -- i.e., Aurora Sun, Aurora... | Aurora Cannabis increases production at its largest grow farm by more than 50% Last week, my newest published production list once again became outdated, thanks to Aurora Cannabis (NYSE: ACB). However, to support Aurora's push into overseas markets, Aurora is expanding the facility by 33% to 1.62 million square feet. S... |
38505.0 | 2019-04-16 00:00:00 UTC | Why Sweden's Government Bought Aurora Cannabis and Canopy Growth Stock | ACB | https://www.nasdaq.com/articles/why-swedens-government-bought-aurora-cannabis-and-canopy-growth-stock-2019-04-16 | nan | nan | On average, more than 32 million shares of Aurora Cannabis (NYSE: ACB) are traded on the New York Stock Exchange (NYSE). For Canopy Growth (NYSE: CGC), the average trading volume is much lower -- around 8 million shares. There's no way to know who's doing all this buying and selling of these top Canadian marijuana stoc... | On average, more than 32 million shares of Aurora Cannabis (NYSE: ACB) are traded on the New York Stock Exchange (NYSE). However, Johan Floren, head of communications and market management at AP7, stated that it's possible that cannabis stocks could be included on the AP7 fund blacklist in the future, according to Affa... | On average, more than 32 million shares of Aurora Cannabis (NYSE: ACB) are traded on the New York Stock Exchange (NYSE). Canada's Public Sector Pension Investment Board (PSP) bought shares of four marijuana producers last year -- Aurora, Canopy Growth, Aphria, and Cronos Group. Pension attention Does it really matter t... | On average, more than 32 million shares of Aurora Cannabis (NYSE: ACB) are traded on the New York Stock Exchange (NYSE). Pension attention Does it really matter that government-run pension funds are buying shares of marijuana stocks like Aurora Cannabis and Canopy Growth? It's another thing altogether when a pension fu... | On average, more than 32 million shares of Aurora Cannabis (NYSE: ACB) are traded on the New York Stock Exchange (NYSE). And why Aurora Cannabis and Canopy Growth? Pension attention Does it really matter that government-run pension funds are buying shares of marijuana stocks like Aurora Cannabis and Canopy Growth? |
38506.0 | 2019-04-16 00:00:00 UTC | What Aphria's Poor Performance Could Mean for Other Canadian Marijuana Stocks | ACB | https://www.nasdaq.com/articles/what-aphrias-poor-performance-could-mean-other-canadian-marijuana-stocks-2019-04-16 | nan | nan | So far, only one Canadian marijuana producer has reported quarterly results that include sales in 2019. But when Aphria (NYSE: APHA) announced its results for the quarter ended Feb. 28, it wasn't what investors had hoped for.
The company's share price tanked Monday on its disappointing fiscal Q3 numbers. The bigger que... | Could Aphria's poor performance be the canary in the coal mine signaling trouble ahead for other top Canadian marijuana stocks, including Aurora Cannabis (NYSE: ACB), Canopy Growth (NYSE: CGC), and Cronos Group (NASDAQ: CRON)? Aphria's only good news related to the top line was the inclusion of CA$57.6 million in distr... | Could Aphria's poor performance be the canary in the coal mine signaling trouble ahead for other top Canadian marijuana stocks, including Aurora Cannabis (NYSE: ACB), Canopy Growth (NYSE: CGC), and Cronos Group (NASDAQ: CRON)? So far, only one Canadian marijuana producer has reported quarterly results that include sale... | Could Aphria's poor performance be the canary in the coal mine signaling trouble ahead for other top Canadian marijuana stocks, including Aurora Cannabis (NYSE: ACB), Canopy Growth (NYSE: CGC), and Cronos Group (NASDAQ: CRON)? Aurora Cannabis CEO Terry Booth mentioned in the company's most recentearnings conference cal... | Could Aphria's poor performance be the canary in the coal mine signaling trouble ahead for other top Canadian marijuana stocks, including Aurora Cannabis (NYSE: ACB), Canopy Growth (NYSE: CGC), and Cronos Group (NASDAQ: CRON)? So far, only one Canadian marijuana producer has reported quarterly results that include sale... |
38507.0 | 2019-04-15 00:00:00 UTC | Can You Guess the Identity of These Marijuana Stocks? | ACB | https://www.nasdaq.com/articles/can-you-guess-identity-these-marijuana-stocks-2019-04-15 | nan | nan | There's no argument on Wall Street or among investors that the legal marijuana industry is on track to be one of the fastest-growing industries over the next five to 10 years. Depending on your preferred source, the global cannabis industry could top $31 billion in sales by 2022, and push onward to between $50 billion ... | If you guessed Aurora Cannabis (NYSE: ACB), then you were correct. The second marijuana stock is substantially cheaper than the other two in terms of market cap per peak kilogram potential, but you'll note that a number of its balance sheet metrics, such as cash and goodwill, are worrisome. Aurora Cannabis has frequent... | If you guessed Aurora Cannabis (NYSE: ACB), then you were correct. Marijuana stock A: Cash represents 31% of its market cap Forward price-to-earnings ratio of 234 Current price-to-sales ratio of 665 Overseas presence in four countries Approximately $48,741 in market cap per kilogram of peak cannabis produced Marijuana ... | If you guessed Aurora Cannabis (NYSE: ACB), then you were correct. Marijuana stock A: Cash represents 31% of its market cap Forward price-to-earnings ratio of 234 Current price-to-sales ratio of 665 Overseas presence in four countries Approximately $48,741 in market cap per kilogram of peak cannabis produced Marijuana ... | If you guessed Aurora Cannabis (NYSE: ACB), then you were correct. Marijuana stock A is... But Cronos Group is going to need a lot more than simply cash to be relevant in the marijuana space. |
38508.0 | 2019-04-14 00:00:00 UTC | 1 Key Area Where Aurora Cannabis Is Beating Canopy Growth, Cronos Group, and Tilray | ACB | https://www.nasdaq.com/articles/1-key-area-where-aurora-cannabis-beating-canopy-growth-cronos-group-and-tilray-2019-04-0 | nan | nan | What's the best-performing big Canadian marijuana stock so far in 2019, with "big" defined as having a market cap of $3 billion or more? It's not Canopy Growth (NYSE: CGC) . Nor is it Cronos Group (NASDAQ: CRON) . Scratch Tilray (NASDAQ: TLRY) off the list, too. The biggest year-to-date winner in terms of stock perform... | The biggest year-to-date winner in terms of stock performance is Aurora Cannabis (NYSE: ACB) . It's supplying medical cannabis in several other European countries, including Czech Republic, Denmark, Italy, Luxembourg, Malta, Poland, and the United Kingdom. Perhaps the biggest hurdle for Aurora in staying on top in glob... | The biggest year-to-date winner in terms of stock performance is Aurora Cannabis (NYSE: ACB) . In its last quarter , Aurora reported $2.9 million Canadian (US$2.2 million) in sales to European markets. The big marijuana producer's international sales also increased at a faster pace than Aurora's did. | The biggest year-to-date winner in terms of stock performance is Aurora Cannabis (NYSE: ACB) . Still, not only is its stock performance outperforming these other three companies, but Aurora is also beating Canopy Growth, Cronos, and Tilray in another key area. Why Aurora could keep winning Canopy Growth nearly caught u... | The biggest year-to-date winner in terms of stock performance is Aurora Cannabis (NYSE: ACB) . What's the best-performing big Canadian marijuana stock so far in 2019, with "big" defined as having a market cap of $3 billion or more? Still, not only is its stock performance outperforming these other three companies, but ... |
38509.0 | 2019-04-14 00:00:00 UTC | 1 Key Area Where Aurora Cannabis Is Beating Canopy Growth, Cronos Group, and Tilray | ACB | https://www.nasdaq.com/articles/1-key-area-where-aurora-cannabis-beating-canopy-growth-cronos-group-and-tilray-2019-04-14 | nan | nan | What's the best-performing big Canadian marijuana stock so far in 2019, with "big" defined as having a market cap of $3 billion or more? It's not Canopy Growth (NYSE: CGC). Nor is it Cronos Group (NASDAQ: CRON). Scratch Tilray (NASDAQ: TLRY) off the list, too. The biggest year-to-date winner in terms of stock performan... | The biggest year-to-date winner in terms of stock performance is Aurora Cannabis (NYSE: ACB). It's supplying medical cannabis in several other European countries, including Czech Republic, Denmark, Italy, Luxembourg, Malta, Poland, and the United Kingdom. Perhaps the biggest hurdle for Aurora in staying on top in globa... | The biggest year-to-date winner in terms of stock performance is Aurora Cannabis (NYSE: ACB). In its last quarter, Aurora reported $2.9 million Canadian (US$2.2 million) in sales to European markets. The big marijuana producer's international sales also increased at a faster pace than Aurora's did. | The biggest year-to-date winner in terms of stock performance is Aurora Cannabis (NYSE: ACB). Still, not only is its stock performance outperforming these other three companies, but Aurora is also beating Canopy Growth, Cronos, and Tilray in another key area. Why Aurora could keep winning Canopy Growth nearly caught up... | The biggest year-to-date winner in terms of stock performance is Aurora Cannabis (NYSE: ACB). What's the best-performing big Canadian marijuana stock so far in 2019, with "big" defined as having a market cap of $3 billion or more? Still, not only is its stock performance outperforming these other three companies, but A... |
38510.0 | 2019-04-14 00:00:00 UTC | Earnings Estimates Are Tumbling for These Pot Stocks | ACB | https://www.nasdaq.com/articles/earnings-estimates-are-tumbling-these-pot-stocks-2019-04-14 | nan | nan | Incredible growth opportunities in the stock market arguably come about just once or twice per generation. The legalization of marijuana in Canada this past October, and in more than three dozen countries around the world in recent years, just might be this generation's incredible growth story.
Last year, Arcview Marke... | Aurora Cannabis In terms of production, no marijuana stock tops Aurora Cannabis (NYSE: ACB), which is currently producing at an annualized run-rate of more than 150,000 kilos a year as of the end of March, and looks to be on track for 700,000 kilos at its peak in perhaps 2021 or 2022. Being the leading producer means h... | Aurora Cannabis In terms of production, no marijuana stock tops Aurora Cannabis (NYSE: ACB), which is currently producing at an annualized run-rate of more than 150,000 kilos a year as of the end of March, and looks to be on track for 700,000 kilos at its peak in perhaps 2021 or 2022. According to Wall Street, Aurora w... | Aurora Cannabis In terms of production, no marijuana stock tops Aurora Cannabis (NYSE: ACB), which is currently producing at an annualized run-rate of more than 150,000 kilos a year as of the end of March, and looks to be on track for 700,000 kilos at its peak in perhaps 2021 or 2022. According to Wall Street, Aurora w... | Aurora Cannabis In terms of production, no marijuana stock tops Aurora Cannabis (NYSE: ACB), which is currently producing at an annualized run-rate of more than 150,000 kilos a year as of the end of March, and looks to be on track for 700,000 kilos at its peak in perhaps 2021 or 2022. According to Wall Street, Tilray w... |
38511.0 | 2019-04-13 00:00:00 UTC | Why Is Legalizing Pot Proving So Difficult in the United States? | ACB | https://www.nasdaq.com/articles/why-legalizing-pot-proving-so-difficult-united-states-2019-04-13 | nan | nan | The marijuana industry has appeared nothing short of unstoppable on a global scale in recent years. To our north, Canada became the first industrialized country in the world to legalize recreational cannabis this past October.
Meanwhile, to our south, Mexico gave the green light to medical marijuana in June 2017. Nowad... | Also in mid-January, the highest projected pot producer in Canada, Aurora Cannabis (NYSE: ACB), detailed its imminent entrance into the U.S. hemp industry. Since Republicans control the Senate and the Oval Office, there's simply no pressing need to push for legalization, even with the American public firmly in favor of... | Also in mid-January, the highest projected pot producer in Canada, Aurora Cannabis (NYSE: ACB), detailed its imminent entrance into the U.S. hemp industry. In Gallup's October 2018 poll, 75% of self-identified Democrats and 71% of Independents favored legalization, compared to just 53% of self-identified Republicans. E... | Also in mid-January, the highest projected pot producer in Canada, Aurora Cannabis (NYSE: ACB), detailed its imminent entrance into the U.S. hemp industry. In order for cannabis to really have a shot at legalization, we'd probably need to see Democrats hold a majority of congressional seats, and the economic benefits o... | Also in mid-January, the highest projected pot producer in Canada, Aurora Cannabis (NYSE: ACB), detailed its imminent entrance into the U.S. hemp industry. On the other hand, the U.S. federal government has been largely unwavering on its view of marijuana, holding firm on its Schedule I classification. While both Canop... |
38512.0 | 2019-04-12 00:00:00 UTC | Aurora Cannabis Marijuana Peak Production Leaps Higher | ACB | https://www.nasdaq.com/articles/aurora-cannabis-marijuana-peak-production-leaps-higher-2019-04-12 | nan | nan | Aurora Cannabis (NYSE: ACB) is Canada's second-largest marijuana company by revenue behind Canopy Growth (NYSE: CGC), but expansion projects could catapult it into first place someday. Aurora Cannabis went into this week with funded expansion projects targeting over 550,000 kilograms annually and exiting this week, its... | Aurora Cannabis (NYSE: ACB) is Canada's second-largest marijuana company by revenue behind Canopy Growth (NYSE: CGC), but expansion projects could catapult it into first place someday. Overcoming bottlenecks After opening on Oct. 17, Canada's legal recreational market sales were CA$152 million in the fourth quarter, an... | Aurora Cannabis (NYSE: ACB) is Canada's second-largest marijuana company by revenue behind Canopy Growth (NYSE: CGC), but expansion projects could catapult it into first place someday. Aurora Cannabis went into this week with funded expansion projects targeting over 550,000 kilograms annually and exiting this week, its... | Aurora Cannabis (NYSE: ACB) is Canada's second-largest marijuana company by revenue behind Canopy Growth (NYSE: CGC), but expansion projects could catapult it into first place someday. Of that, Canopy Growth captured 27% market share, delivering CA$83 million in net sales last quarter, including CA$58 million in adult-... | Aurora Cannabis (NYSE: ACB) is Canada's second-largest marijuana company by revenue behind Canopy Growth (NYSE: CGC), but expansion projects could catapult it into first place someday. Last year, Canada became the first G7 nation with legal, medical and recreational, adult-use markets nationwide. A lot of that increase... |
38513.0 | 2019-04-12 00:00:00 UTC | Aurora Cannabis Marijuana Peak Production Leaps Higher | ACB | https://www.nasdaq.com/articles/aurora-cannabis-marijuana-peak-production-leaps-higher-2019-04-12-0 | nan | nan | Aurora Cannabis (NYSE: ACB) is Canada's second-largest marijuana company by revenue behind Canopy Growth (NYSE: CGC) , but expansion projects could catapult it into first place someday. Aurora Cannabis went into this week with funded expansion projects targeting over 550,000 kilograms annually and exiting this week, it... | Aurora Cannabis (NYSE: ACB) is Canada's second-largest marijuana company by revenue behind Canopy Growth (NYSE: CGC) , but expansion projects could catapult it into first place someday. Overcoming bottlenecks After opening on Oct. 17, Canada's legal recreational market sales were CA$152 million in the fourth quarter, a... | Aurora Cannabis (NYSE: ACB) is Canada's second-largest marijuana company by revenue behind Canopy Growth (NYSE: CGC) , but expansion projects could catapult it into first place someday. Aurora Cannabis went into this week with funded expansion projects targeting over 550,000 kilograms annually and exiting this week, it... | Aurora Cannabis (NYSE: ACB) is Canada's second-largest marijuana company by revenue behind Canopy Growth (NYSE: CGC) , but expansion projects could catapult it into first place someday. Of that, Canopy Growth captured 27% market share, delivering CA$83 million in net sales last quarter, including CA$58 million in adult... | Aurora Cannabis (NYSE: ACB) is Canada's second-largest marijuana company by revenue behind Canopy Growth (NYSE: CGC) , but expansion projects could catapult it into first place someday. Last year, Canada became the first G7 nation with legal, medical and recreational, adult-use markets nationwide. A lot of that increas... |
38514.0 | 2019-04-11 00:00:00 UTC | A Detailed Look at How Aurora Cannabis Generates Revenue | ACB | https://www.nasdaq.com/articles/detailed-look-how-aurora-cannabis-generates-revenue-2019-04-11 | nan | nan | Over the next four years, there's arguably no industry that's expected to grow faster and more consistently on a global scale than the legal marijuana industry. Between 2018 and 2022, Arcview Market Research and BDS Analytics have called for a compound annual sales growth rate of 26.6%, leading to $31.3 billion in reve... | Of course, no pot stock has been more popular or polarizing than Aurora Cannabis (NYSE: ACB), which is a favorite among millennial investors. Between 2018 and 2022, Arcview Market Research and BDS Analytics have called for a compound annual sales growth rate of 26.6%, leading to $31.3 billion in revenue by 2022. When o... | Of course, no pot stock has been more popular or polarizing than Aurora Cannabis (NYSE: ACB), which is a favorite among millennial investors. In the second quarter, CA$25.99 million (48% of total sales) was recognized by the medical marijuana segment, with CA$21.58 million (40% of total sales) going to the consumer (i.... | Of course, no pot stock has been more popular or polarizing than Aurora Cannabis (NYSE: ACB), which is a favorite among millennial investors. Breaking down Aurora's sales by geographic region For the quarter, Aurora Cannabis wound up reporting 62 million Canadian dollars in gross revenue, as well as CA$7.82 million in ... | Of course, no pot stock has been more popular or polarizing than Aurora Cannabis (NYSE: ACB), which is a favorite among millennial investors. These are three highly populated provinces (relative to Canada's Atlantic provinces), but interestingly enough the adults in these provinces tend to use cannabis less often than ... |
38515.0 | 2019-04-11 00:00:00 UTC | Why Today’s Marijuana Stocks Could Turn Into $100 Billion Companies | ACB | https://www.nasdaq.com/articles/why-todays-marijuana-stocks-could-turn-100-billion-companies-2019-04-11-0 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
One of the biggest crazes in the stock market over the past year has been the marijuana stock boom, and one of the biggest knocks against that craze has been the valuation of marijuana stocks.
Specifically, the "Big 4" marijuana stocks - Canopy (NYSE: CGC )... | Specifically, the "Big 4" marijuana stocks - Canopy (NYSE: CGC ), Aurora (NYSE: ACB ), Cronos (NASDAQ: CRON ), and Tilray (NASDAQ: TLRY ) - all have market caps of over $5 billion. My top picks are CGC stock and ACB stock. As of this writing, Luke Lango was long CGC stock and ACB stock. | Specifically, the "Big 4" marijuana stocks - Canopy (NYSE: CGC ), Aurora (NYSE: ACB ), Cronos (NASDAQ: CRON ), and Tilray (NASDAQ: TLRY ) - all have market caps of over $5 billion. My top picks are CGC stock and ACB stock. As of this writing, Luke Lango was long CGC stock and ACB stock. | Specifically, the "Big 4" marijuana stocks - Canopy (NYSE: CGC ), Aurora (NYSE: ACB ), Cronos (NASDAQ: CRON ), and Tilray (NASDAQ: TLRY ) - all have market caps of over $5 billion. My top picks are CGC stock and ACB stock. As of this writing, Luke Lango was long CGC stock and ACB stock. | Specifically, the "Big 4" marijuana stocks - Canopy (NYSE: CGC ), Aurora (NYSE: ACB ), Cronos (NASDAQ: CRON ), and Tilray (NASDAQ: TLRY ) - all have market caps of over $5 billion. My top picks are CGC stock and ACB stock. As of this writing, Luke Lango was long CGC stock and ACB stock. |
38516.0 | 2019-04-11 00:00:00 UTC | Why Today’s Marijuana Stocks Could Turn Into $100 Billion Companies | ACB | https://www.nasdaq.com/articles/why-todays-marijuana-stocks-could-turn-100-billion-companies-2019-04-11 | nan | nan | One of the biggest crazes in the stock market over the past year has been the marijuana stock boom, and one of the biggest knocks against that craze has been the valuation of marijuana stocks.
Specifically, the “Big 4” marijuana stocks – Canopy (NYSE:), Aurora (NYSE:), Cronos (NASDAQ:), and Tilray (NASDAQ:) – all have ... | My top picks are CGC stock and ACB stock. As of this writing, Luke Lango was long CGC stock and ACB stock. As a result, a popular view on marijuana stocks is that, given the fact that they are trading at 30-plus times their sales over the past year, they are wildly overvalued. | My top picks are CGC stock and ACB stock. As of this writing, Luke Lango was long CGC stock and ACB stock. Once it is, the legal cannabis market around the world should be comparable in size to the global alcoholic beverage and tobacco markets. | My top picks are CGC stock and ACB stock. As of this writing, Luke Lango was long CGC stock and ACB stock. One of the biggest crazes in the stock market over the past year has been the marijuana stock boom, and one of the biggest knocks against that craze has been the valuation of marijuana stocks. | My top picks are CGC stock and ACB stock. As of this writing, Luke Lango was long CGC stock and ACB stock. The global tobacco market is valued at $700 billion. |
38517.0 | 2019-04-11 00:00:00 UTC | Cannabis Stocks to Watch Ahead of the States Bill | ACB | https://www.nasdaq.com/articles/cannabis-stocks-watch-ahead-states-bill-2019-04-11 | nan | nan | Cannabis stocks are in a holding pattern right now — consider that the ETFMG Alternative Harvest ETF (NYSEARCA:) has barely budged in the last month. Markets are waiting on the bipartisan legislation proposed in both the House and Senate to create protections for the states legalizing cannabis to play out. If the secto... | ACB shares are up over 70% year-to-date already. Markets are waiting on the bipartisan legislation proposed in both the House and Senate to create protections for the states legalizing cannabis to play out. 5, the CEO of Constellation Brands (NYSE:) told CNBC that Canopy Growth (NYSEQ:) could make more than $1 billion ... | ACB shares are up over 70% year-to-date already. 5, the CEO of Constellation Brands (NYSE:) told CNBC that Canopy Growth (NYSEQ:) could make more than $1 billion in revenue by the end of its fiscal year. If more states legalize the substance, then Canopy, Constellation Brands and Aurora Cannabis could all, in turn, rew... | ACB shares are up over 70% year-to-date already. If more states legalize the substance, then Canopy, Constellation Brands and Aurora Cannabis could all, in turn, reward shareholders with good results. Such positive benefits to the economy and job market are something for states to look forward to from cannabis legaliza... | ACB shares are up over 70% year-to-date already. If the sector wins a favorable decision, it could start rallying again as it did for much of 2019. 5, the CEO of Constellation Brands (NYSE:) told CNBC that Canopy Growth (NYSEQ:) could make more than $1 billion in revenue by the end of its fiscal year. |
38518.0 | 2019-04-11 00:00:00 UTC | Don’t Believe Everything You Read About Marijuana Stocks | ACB | https://www.nasdaq.com/articles/dont-believe-everything-you-read-about-marijuana-stocks-2019-04-11 | nan | nan | Marijuana stocks have become much more accepted by mainstream investors in the past few years. However, just because investing in cannabis is getting more common doesn’t mean it’s not dangerous territory for investors.
A parade of marijuana stocks has listed on major U.S. exchanges since the beginning of 2018. In addit... | Those schemes involve companies or third parties flooding message boards and social media platforms with fake news about a stock to drive its price higher. In a press release, Medmen said it “disclaims any potentially exaggerated or misleading statements contained in the materials” distributed online by Winning Media. ... | Medmen’s Fake News Since information about OTC-listed stocks can be difficult to obtain, greedy traders and greedy companies can take advantage of the situation. Yet just last month, Medmen admitted to using an agreement with a company called Winning Media to promote MMNFF stock. However, given how thinly-traded the O... | The Dangers Of OTC Stocks Marijuana stocks like Canopy Growth Corp (NYSE: ), Tilray (NASDAQ: ) and Aurora Cannabis (NYSE: ) have gained legitimacy in the past year by transitioning to the NYSE and Nasdaq exchanges. Many OTC stocks trade for under $1 per share, and it’s common for OTC stocks to provide little financial ... | However, given how thinly-traded the OTC market is, stock promoters don’t need companies’ permission to promote stocks. The promoters can simply take a position in a stock, spread fake news online and cash out. Unfortunately, some U.S. cannabis companies still have a long way to go. |
38519.0 | 2019-04-11 00:00:00 UTC | Aurora Cannabis Is Boosting Its Capacity Even More: Crazy, or Crazy Like a Fox? | ACB | https://www.nasdaq.com/articles/aurora-cannabis-boosting-its-capacity-even-more-crazy-or-crazy-fox-2019-04-11 | nan | nan | You might not think that Aurora Cannabis (NYSE: ACB) would need additional production capacity. After all, the company is already on track to have an annualized production run rate of well over 500,000 kilograms by the middle of next year. With its funded capacity of over 625,000 kilograms per year, Aurora ranks in a s... | You might not think that Aurora Cannabis (NYSE: ACB) would need additional production capacity. With its funded capacity of over 625,000 kilograms per year, Aurora ranks in a strong first-place position among Canadian marijuana growers. Aurora Sun will have a glass roof along with a system to recapture rainwater and me... | You might not think that Aurora Cannabis (NYSE: ACB) would need additional production capacity. Originally, Aurora planned for Aurora Sun to have 1.2 million square feet of growing space. The company said that additional growing space is being added at the Aurora Sun facility "to support rapidly growing global demand f... | You might not think that Aurora Cannabis (NYSE: ACB) would need additional production capacity. An even bigger Aurora Sun Aurora is in the process of constructing its facility, dubbed Aurora Sun, in Medicine Hat, Alberta. Don't question their sanity yet Does Aurora's plan to boost capacity at the Aurora Sun facility ma... | You might not think that Aurora Cannabis (NYSE: ACB) would need additional production capacity. The company said that additional growing space is being added at the Aurora Sun facility "to support rapidly growing global demand for high-quality medical cannabis in Canada and abroad." But Aurora could very well be right ... |
38520.0 | 2019-04-11 00:00:00 UTC | Aphria’s $1 Billion Target: Fantasy or Reality? | ACB | https://www.nasdaq.com/articles/aphrias-1-billion-target-fantasy-or-reality-2019-04-11-0 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
So, I have a question: is Aphria (NYSE: APHA ) putting a $1 billion revenue target out there to push Aphria stock higher, or does it have the infrastructure and brands to deliver the goods?
10 Dow Jones Stocks Holding the Blue Chip Index Back
Source: Shutte... | The Bottom Line on Aphria Stock If you compare Aphria to the other major players in Canada, Aphria stock is trading at a price-to-sales multiple of 48 , less than either Canopy or Aurora Cannabis (NYSE: ACB ) at 83 and 72, respectively. 10 Dow Jones Stocks Holding the Blue Chip Index Back Source: Shutterstock As Canada... | The Bottom Line on Aphria Stock If you compare Aphria to the other major players in Canada, Aphria stock is trading at a price-to-sales multiple of 48 , less than either Canopy or Aurora Cannabis (NYSE: ACB ) at 83 and 72, respectively. InvestorPlace - Stock Market News, Stock Advice & Trading Tips So, I have a questio... | The Bottom Line on Aphria Stock If you compare Aphria to the other major players in Canada, Aphria stock is trading at a price-to-sales multiple of 48 , less than either Canopy or Aurora Cannabis (NYSE: ACB ) at 83 and 72, respectively. InvestorPlace - Stock Market News, Stock Advice & Trading Tips So, I have a questio... | The Bottom Line on Aphria Stock If you compare Aphria to the other major players in Canada, Aphria stock is trading at a price-to-sales multiple of 48 , less than either Canopy or Aurora Cannabis (NYSE: ACB ) at 83 and 72, respectively. It's a Realistic Target Aphria interim CEO and chairman Irwin Simon believes the co... |
38521.0 | 2019-04-11 00:00:00 UTC | Aphria’s $1 Billion Target: Fantasy or Reality? | ACB | https://www.nasdaq.com/articles/aphrias-1-billion-target-fantasy-or-reality-2019-04-11 | nan | nan | So, I have a question: is Aphria (NYSE:) putting a $1 billion revenue target out there to push Aphria stock higher, or does it have the infrastructure and brands to deliver the goods?
Source: Shutterstock
As Canada’s cannabis industry continues to evolve, the major players all are staking out their positions domestical... | The Bottom Line on Aphria Stock If you compare Aphria to the other major players in Canada, Aphria stock is trading at a price-to-sales multiple of , less than either Canopy or Aurora Cannabis (NYSE:ACB) at 83 and 72, respectively. With countries such as the U.S. offering greater potential than the Canadian market base... | The Bottom Line on Aphria Stock If you compare Aphria to the other major players in Canada, Aphria stock is trading at a price-to-sales multiple of , less than either Canopy or Aurora Cannabis (NYSE:ACB) at 83 and 72, respectively. “There are so many opportunities to get to profitability in our Canadian business.” In i... | The Bottom Line on Aphria Stock If you compare Aphria to the other major players in Canada, Aphria stock is trading at a price-to-sales multiple of , less than either Canopy or Aurora Cannabis (NYSE:ACB) at 83 and 72, respectively. It’s a Realistic Target Aphria interim CEO and chairman Irwin Simon believes the company... | The Bottom Line on Aphria Stock If you compare Aphria to the other major players in Canada, Aphria stock is trading at a price-to-sales multiple of , less than either Canopy or Aurora Cannabis (NYSE:ACB) at 83 and 72, respectively. It’s a Realistic Target Aphria interim CEO and chairman Irwin Simon believes the company... |
38522.0 | 2019-04-11 00:00:00 UTC | Don’t Believe Everything You Read About Marijuana Stocks | ACB | https://www.nasdaq.com/articles/dont-believe-everything-you-read-about-marijuana-stocks-2019-04-11-0 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Marijuana stocks have become much more accepted by mainstream investors in the past few years. However, just because investing in cannabis is getting more common doesn't mean it's not dangerous territory for investors.
A parade of marijuana stocks has liste... | The Dangers Of OTC Stocks Marijuana stocks like Canopy Growth Corp (NYSE: CGC ), Tilray (NASDAQ: TLRY ) and Aurora Cannabis (NYSE: ACB ) have gained legitimacy in the past year by transitioning to the NYSE and Nasdaq exchanges. Those schemes involve companies or third parties flooding message boards and social media pl... | The Dangers Of OTC Stocks Marijuana stocks like Canopy Growth Corp (NYSE: CGC ), Tilray (NASDAQ: TLRY ) and Aurora Cannabis (NYSE: ACB ) have gained legitimacy in the past year by transitioning to the NYSE and Nasdaq exchanges. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Marijuana stocks have become ... | The Dangers Of OTC Stocks Marijuana stocks like Canopy Growth Corp (NYSE: CGC ), Tilray (NASDAQ: TLRY ) and Aurora Cannabis (NYSE: ACB ) have gained legitimacy in the past year by transitioning to the NYSE and Nasdaq exchanges. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Marijuana stocks have become ... | The Dangers Of OTC Stocks Marijuana stocks like Canopy Growth Corp (NYSE: CGC ), Tilray (NASDAQ: TLRY ) and Aurora Cannabis (NYSE: ACB ) have gained legitimacy in the past year by transitioning to the NYSE and Nasdaq exchanges. However, just because investing in cannabis is getting more common doesn't mean it's not dan... |
38523.0 | 2019-04-10 00:00:00 UTC | 7 Marijuana Companies: Which Pot Stocks Should You Buy? | ACB | https://www.nasdaq.com/articles/7-marijuana-companies%3A-which-pot-stocks-should-you-buy-2019-04-10 | nan | nan | Of the 46 marijuana stocks in the North American Marijuana Index, I guess that a handful of them are currently making money. That’s the extent of it.
From that perspective, it’s a very daunting task picking the winners from the losers, because they all tell a good tale. But when it comes to separating the wheat from th... | Aurora Cannabis (ACB) Aurora Cannabis (NYSE:) has been making a lot of moves lately to strengthen its corporate governance and international reputation including bringing activist investor Nelson Peltz on as a strategic advisor. Since Bloomberg’s article about the billionaire’s financial wherewithal, Tilray’s stock has... | Aurora Cannabis (ACB) Aurora Cannabis (NYSE:) has been making a lot of moves lately to strengthen its corporate governance and international reputation including bringing activist investor Nelson Peltz on as a strategic advisor. Marijuana Stocks to Sell: Tilray (TLRY) Tilray (NASDAQ:) CEO Brendan Kennedy has done well ... | Aurora Cannabis (ACB) Aurora Cannabis (NYSE:) has been making a lot of moves lately to strengthen its corporate governance and international reputation including bringing activist investor Nelson Peltz on as a strategic advisor. Cronos Group (CRON) I’m a big fan of Cronos Group (NASDAQ:) stock because it had the good s... | Aurora Cannabis (ACB) Aurora Cannabis (NYSE:) has been making a lot of moves lately to strengthen its corporate governance and international reputation including bringing activist investor Nelson Peltz on as a strategic advisor. Marijuana Stocks to Sell: Tilray (TLRY) Tilray (NASDAQ:) CEO Brendan Kennedy has done well ... |
38524.0 | 2019-04-10 00:00:00 UTC | TSX May Start Higher on Rising Crude Prices | ACB | https://www.nasdaq.com/articles/tsx-may-start-higher-rising-crude-prices-2019-04-10 | nan | nan | Canada's benchmark index looked set to start the Wednesday session in the green, with help from rising oil prices.
Oil resumed its rise early on Wednesday following a day-prior drop from five-month highs ahead of key U.S. inventory data as a report released a day earlier said U.S. crude inventories rose by more than fo... | Investors will also keep an eye on Aurora Cannabis (ACB, ACB.TO) after it said that its Aurora Sun facility will be expanded to 1.62 million square feet, representing a 33% increase from its originally planned 1.2 million square feet. Canada's benchmark index looked set to start the Wednesday session in the green, with... | Investors will also keep an eye on Aurora Cannabis (ACB, ACB.TO) after it said that its Aurora Sun facility will be expanded to 1.62 million square feet, representing a 33% increase from its originally planned 1.2 million square feet. Canada's benchmark index looked set to start the Wednesday session in the green, with... | Investors will also keep an eye on Aurora Cannabis (ACB, ACB.TO) after it said that its Aurora Sun facility will be expanded to 1.62 million square feet, representing a 33% increase from its originally planned 1.2 million square feet. Oil resumed its rise early on Wednesday following a day-prior drop from five-month hi... | Investors will also keep an eye on Aurora Cannabis (ACB, ACB.TO) after it said that its Aurora Sun facility will be expanded to 1.62 million square feet, representing a 33% increase from its originally planned 1.2 million square feet. Canada's benchmark index looked set to start the Wednesday session in the green, with... |
38525.0 | 2019-04-10 00:00:00 UTC | Aurora Cannabis Is Facing a Tricky Catch-22 | ACB | https://www.nasdaq.com/articles/aurora-cannabis-facing-tricky-catch-22-2019-04-10 | nan | nan | The marijuana industry is budding into a big business model before our eyes. Gone is the notion that this is an industry that simply sells dried cannabis to casual users. Now, the legal weed industry consists of a number of cannabis alternatives, such as oils, vapes, concentrates, topicals, and even beverages, and it's... | One such company that's the bee's knees of pot stock investors is Aurora Cannabis (NYSE: ACB). Now, the legal weed industry consists of a number of cannabis alternatives, such as oils, vapes, concentrates, topicals, and even beverages, and it's targeted at everyone from medical marijuana patients to upscale recreationa... | One such company that's the bee's knees of pot stock investors is Aurora Cannabis (NYSE: ACB). This broad reach and ongoing maturation is a big reason Cowen Group expects the global industry to hit $75 billion in annual sales by 2030. Most alternative pot products, including nonalcoholic cannabis-infused beverages, wil... | One such company that's the bee's knees of pot stock investors is Aurora Cannabis (NYSE: ACB). Aurora's missing piece However, there's one pretty big piece of the puzzle missing for Aurora that a few of its larger peers, Canopy Growth and Cronos Group, have locked up --namely, securing a brand-name partner. Aurora Cann... | One such company that's the bee's knees of pot stock investors is Aurora Cannabis (NYSE: ACB). But it's more than just production that has investors gravitating to Aurora. Aurora Cannabis' Catch-22 On one hand, Aurora Cannabis is seeking a partner that's willing to invest in the company, much the same way Constellation... |
38526.0 | 2019-04-10 00:00:00 UTC | 7 Marijuana Companies: Which Pot Stocks Should You Buy? | ACB | https://www.nasdaq.com/articles/7-marijuana-companies%3A-which-pot-stocks-should-you-buy-2019-04-10-0 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Of the 46 marijuana stocks in the North American Marijuana Index, I guess that a handful of them are currently making money. That's the extent of it.
From that perspective, it's a very daunting task picking the winners from the losers, because they all tell... | Aurora Cannabis (ACB) Aurora Cannabis (NYSE: ACB ) has been making a lot of moves lately to strengthen its corporate governance and international reputation including bringing activist investor Nelson Peltz on as a strategic advisor. Since Bloomberg's article about the billionaire's financial wherewithal, Tilray's stoc... | Aurora Cannabis (ACB) Aurora Cannabis (NYSE: ACB ) has been making a lot of moves lately to strengthen its corporate governance and international reputation including bringing activist investor Nelson Peltz on as a strategic advisor. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Of the 46 marijuana sto... | Aurora Cannabis (ACB) Aurora Cannabis (NYSE: ACB ) has been making a lot of moves lately to strengthen its corporate governance and international reputation including bringing activist investor Nelson Peltz on as a strategic advisor. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Of the 46 marijuana sto... | Aurora Cannabis (ACB) Aurora Cannabis (NYSE: ACB ) has been making a lot of moves lately to strengthen its corporate governance and international reputation including bringing activist investor Nelson Peltz on as a strategic advisor. Marijuana Stocks to Sell: Tilray (TLRY) Tilray (NASDAQ: TLRY ) CEO Brendan Kennedy has... |
38527.0 | 2019-04-09 00:00:00 UTC | Why Marijuana Stock Aurora Cannabis Popped 21.9% in March | ACB | https://www.nasdaq.com/articles/why-marijuana-stock-aurora-cannabis-popped-219-march-2019-04-10 | nan | nan | What happened
Shares of Aurora Cannabis (NYSE: ACB) surged nearly 22% last month, according to data from S&P Global Market Intelligence, after the Canadian marijuana company received bullish analyst commentary and announced the appointment of a new strategic advisor.
So what
On March 5, investment firm Cowen named Auro... | What happened Shares of Aurora Cannabis (NYSE: ACB) surged nearly 22% last month, according to data from S&P Global Market Intelligence, after the Canadian marijuana company received bullish analyst commentary and announced the appointment of a new strategic advisor. "The company's large cultivation footprint, capable ... | What happened Shares of Aurora Cannabis (NYSE: ACB) surged nearly 22% last month, according to data from S&P Global Market Intelligence, after the Canadian marijuana company received bullish analyst commentary and announced the appointment of a new strategic advisor. "The company's large cultivation footprint, capable ... | What happened Shares of Aurora Cannabis (NYSE: ACB) surged nearly 22% last month, according to data from S&P Global Market Intelligence, after the Canadian marijuana company received bullish analyst commentary and announced the appointment of a new strategic advisor. "The company's large cultivation footprint, capable ... | ACB data by YCharts All told, an investment in Aurora Cannabis comes with plenty of risk, but this Canadian producer is likely to remain one of the more intriguing growth stories within the booming marijuana market in the years ahead. What happened Shares of Aurora Cannabis (NYSE: ACB) surged nearly 22% last month, acc... |
38528.0 | 2019-04-09 00:00:00 UTC | Pre-Market Most Active for Apr 9, 2019 : ZGNX, NVS, QQQ, X, PHAS, GE, AAPL, CHK, SQQQ, NOK, AMD, ACB | ACB | https://www.nasdaq.com/articles/pre-market-most-active-apr-9-2019-zgnx-nvs-qqq-x-phas-ge-aapl-chk-sqqq-nok-amd-acb-2019-04 | nan | nan | The NASDAQ 100 Pre-Market Indicator is down -7.19 to 7,592.55. The total Pre-Market volume is currently 3,593,170 shares traded.
The following are the most active stocks for the pre-market session :
Zogenix, Inc. ( ZGNX ) is -14.25 at $37.60, with 523,489 shares traded. As reported in the last short interest update the... | Aurora Cannabis Inc. ( ACB ) is -0.07 at $8.97, with 98,235 shares traded. ACB's current last sale is 102.11% of the target price of $8.785. The following are the most active stocks for the pre-market session : Zogenix, Inc. ( ZGNX ) is -14.25 at $37.60, with 523,489 shares traded. | The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Aurora Cannabis Inc. ( ACB ) is -0.07 at $8.97, with 98,235 shares traded. ACB's current last sale is 102.11% of the target price of $8.785. | Aurora Cannabis Inc. ( ACB ) is -0.07 at $8.97, with 98,235 shares traded. ACB's current last sale is 102.11% of the target price of $8.785. The total Pre-Market volume is currently 3,593,170 shares traded. | ACB's current last sale is 102.11% of the target price of $8.785. Aurora Cannabis Inc. ( ACB ) is -0.07 at $8.97, with 98,235 shares traded. GE's current last sale is 74.96% of the target price of $12.5. |
38529.0 | 2019-04-09 00:00:00 UTC | Here's Why the 5 Most Popular Marijuana Stocks Aren't Worth Buying | ACB | https://www.nasdaq.com/articles/heres-why-5-most-popular-marijuana-stocks-arent-worth-buying-2019-04-09 | nan | nan | The marijuana industry could seemingly do no wrong in the first quarter. Although the stock market is off to its strongest start since 1991, with the broad-based S&P 500 gaining 13% in the first quarter, it was the Horizons Marijuana Life Sciences ETF, a basket of four dozen variously weighted pot stocks, that took the... | In no particular order, these popular marijuana stocks are Canopy Growth (NYSE: CGC), Aurora Cannabis (NYSE: ACB), Tilray (NASDAQ: TLRY), Cronos Group (NASDAQ: CRON), and Aphria (NYSE: APHA). For example, Canopy Growth and Cronos have forged billion-dollar investment deals with brand-name companies, while Aurora Cannab... | In no particular order, these popular marijuana stocks are Canopy Growth (NYSE: CGC), Aurora Cannabis (NYSE: ACB), Tilray (NASDAQ: TLRY), Cronos Group (NASDAQ: CRON), and Aphria (NYSE: APHA). Canopy Growth: Bringing up the rear on profitability As the largest pot stock in the world, Canopy Growth offers plenty of compe... | In no particular order, these popular marijuana stocks are Canopy Growth (NYSE: CGC), Aurora Cannabis (NYSE: ACB), Tilray (NASDAQ: TLRY), Cronos Group (NASDAQ: CRON), and Aphria (NYSE: APHA). Aurora Cannabis: King of share-based dilution Among millennial investors, there's probably no stock they're more enamored with (... | In no particular order, these popular marijuana stocks are Canopy Growth (NYSE: CGC), Aurora Cannabis (NYSE: ACB), Tilray (NASDAQ: TLRY), Cronos Group (NASDAQ: CRON), and Aphria (NYSE: APHA). Cronos Group: Lagging in production and international expansion Few marijuana stocks have been hotter than Cronos Group to start... |
38530.0 | 2019-04-09 00:00:00 UTC | When Will Aurora Cannabis Make Its Move Into the U.S.? | ACB | https://www.nasdaq.com/articles/when-will-aurora-cannabis-make-its-move-us-2019-04-09 | nan | nan | Aurora Cannabis (NYSE: ACB) can't expand into the U.S. marijuana market. At least, it can't do so and retain its listings on the New York Stock Exchange and Toronto Stock Exchange as long as marijuana remains illegal at the federal level in the U.S.
But two of Aurora's peers, Canopy Growth and Tilray, are already movin... | Aurora Cannabis (NYSE: ACB) can't expand into the U.S. marijuana market. In January 2019, the company invested in Folium Biosciences, the largest vertically integrated producer, manufacturer, and distributor of hemp-derived phytocannabinoids in the U.S. Australis followed up in February by acquiring 100% of Mr. Natural... | Aurora Cannabis (NYSE: ACB) can't expand into the U.S. marijuana market. But while Australis Capital is closely aligned with Aurora Cannabis, the two companies must operate independently to avoid issues related to Aurora's stock listings. Terry Booth was asked about Aurora's U.S. hemp strategy in the company's second-q... | Aurora Cannabis (NYSE: ACB) can't expand into the U.S. marijuana market. But while Australis Capital is closely aligned with Aurora Cannabis, the two companies must operate independently to avoid issues related to Aurora's stock listings. Partnership pathway Don't think that Aurora Cannabis doesn't have something up it... | Aurora Cannabis (NYSE: ACB) can't expand into the U.S. marijuana market. But two of Aurora's peers, Canopy Growth and Tilray, are already moving into the U.S. cannabis market in a different way. 10 stocks we like better than Aurora Cannabis Inc. |
38531.0 | 2019-04-08 00:00:00 UTC | These 14 Pot Stocks Gained at Least 70% in the First Quarter | ACB | https://www.nasdaq.com/articles/these-14-pot-stocks-gained-least-70-first-quarter-2019-04-08 | nan | nan | There's no denying it: Marijuana stocks have been virtually unstoppable since the year began. Although pot stocks more or less tread water during the month of March, the Horizons Marijuana Life Sciences ETF, the very first tradable cannabis exchange-traded fund, and an ETF that currently contains about four dozen marij... | Aurora Cannabis (NYSE: ACB): up 83%. For example, OrganiGram Holdings, which is laser-focused on maximizing production at its Moncton campus in New Brunswick, should produce 113,000 kilos at peak capacity while only using 490,000 square feet of cultivation space. Presumably, The Green Organic Dutchman is still a top-fi... | Aurora Cannabis (NYSE: ACB): up 83%. In March, the largest U.S. marijuana deal in history was announced, with vertically integrated dispensary Harvest Health & Recreation acquiring privately held Verano Holdings for $850 million in an all-stock deal. With Harvest Health already profitable on an operating basis, the exp... | Aurora Cannabis (NYSE: ACB): up 83%. Although pot stocks more or less tread water during the month of March, the Horizons Marijuana Life Sciences ETF, the very first tradable cannabis exchange-traded fund, and an ETF that currently contains about four dozen marijuana stocks of varied weightings, rose by 54% during the ... | Aurora Cannabis (NYSE: ACB): up 83%. But as you might have expected, quite a few pot stocks handily outperformed one of the most followed marijuana ETFs during the first quarter. Image source: Nasdaq. |
38532.0 | 2019-04-08 00:00:00 UTC | Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know | ACB | https://www.nasdaq.com/articles/aurora-cannabis-inc.-acb-stock-sinks-as-market-gains%3A-what-you-should-know-2019-04-08-0 | nan | nan | Aurora Cannabis Inc. (ACB) closed at $9.01 in the latest trading session, marking a -1.74% move from the prior day. This move lagged the S&P 500's daily gain of 0.11%. Elsewhere, the Dow lost 0.32%, while the tech-heavy Nasdaq added 0.19%.
Coming into today, shares of the company had gained 20.98% in the past month. In... | Aurora Cannabis Inc. (ACB) closed at $9.01 in the latest trading session, marking a -1.74% move from the prior day. ACB's full-year Zacks Consensus Estimates are calling for earnings of -$0.17 per share and revenue of $224.47 million. ACB will be looking to display strength as it nears its nex t earnings release. | Click to get this free report Aurora Cannabis Inc. (ACB): Free Stock Analysis Report To read this article on Zacks.com click here. Aurora Cannabis Inc. (ACB) closed at $9.01 in the latest trading session, marking a -1.74% move from the prior day. ACB will be looking to display strength as it nears its nex t earnings re... | ACB's full-year Zacks Consensus Estimates are calling for earnings of -$0.17 per share and revenue of $224.47 million. Aurora Cannabis Inc. (ACB) closed at $9.01 in the latest trading session, marking a -1.74% move from the prior day. ACB will be looking to display strength as it nears its nex t earnings release. | Aurora Cannabis Inc. (ACB) closed at $9.01 in the latest trading session, marking a -1.74% move from the prior day. ACB will be looking to display strength as it nears its nex t earnings release. ACB's full-year Zacks Consensus Estimates are calling for earnings of -$0.17 per share and revenue of $224.47 million. |
38533.0 | 2019-04-08 00:00:00 UTC | 3 Marijuana Stocks With Budding Trade Opportunities | ACB | https://www.nasdaq.com/articles/3-marijuana-stocks-budding-trade-opportunities-2019-04-08 | nan | nan | If you’re asking the question, “what is Wall Street smoking these days?”, you’re not alone. But if it’s green you’re after, look no further than the price charts of this trio of marijuana stocks. Let me explain.
With a gravity-defying broader market now approaching all-time-highs off late December’s almost ubiquitous c... | ACB stock is on InvestorPlace’s short list of cannabis buy recommendations due to the company’s smart-looking acquisition strategy that’s helping leverage its position within the medicinal side of the business. Buy #1: ACB Stock My first of two marijuana stock buys are shares of Aurora Cannabis (NYSE:). On the price ch... | Buy #1: ACB Stock My first of two marijuana stock buys are shares of Aurora Cannabis (NYSE:). Unlike a marijuana stock like Cronos (NASDAQ:) or Canopy Growth (NYSE:) which have seen big gains in 2019; ACB stock’s big picture shows a name that’s done a good deal more work consolidating its gains in a very large base. AC... | Buy #1: ACB Stock My first of two marijuana stock buys are shares of Aurora Cannabis (NYSE:). Unlike a marijuana stock like Cronos (NASDAQ:) or Canopy Growth (NYSE:) which have seen big gains in 2019; ACB stock’s big picture shows a name that’s done a good deal more work consolidating its gains in a very large base. AC... | Buy #1: ACB Stock My first of two marijuana stock buys are shares of Aurora Cannabis (NYSE:). ACB stock is on InvestorPlace’s short list of cannabis buy recommendations due to the company’s smart-looking acquisition strategy that’s helping leverage its position within the medicinal side of the business. On the price ch... |
38534.0 | 2019-04-08 00:00:00 UTC | Cronos Group: 3 Pros, 3 Cons for Buying CRON Stock on This Dip | ACB | https://www.nasdaq.com/articles/cronos-group-3-pros-3-cons-buying-cron-stock-dip-2019-04-08 | nan | nan | Cronos Group (NASDAQ:), a top Canadian cannabis operator, has been showing some weakness lately. Since early March, CRON stock has gone from $23.70 to $18.10, or a drop of about 24%.
Source: Shutterstock
This sudden volatility contrasts with strong optimism earlier this year. However, Cronos Group stock is certainly no... | A research report from the states that the spending is at a whopping $150 billion (this also includes the illicit market) and about 180 million people consume cannabis. MO will help significantly increase distribution as well as assist with developing consumer products and putting together effective marketing campaigns... | Cronos Group (NASDAQ:), a top Canadian cannabis operator, has been showing some weakness lately. Keep in mind that other marijuana shares have also been under some pressure lately or have flat-lined … Just look at Tilray (NASDAQ:), Canopy Growth (NYSE:) and Aurora Cannabis (NYSE:). MO will help significantly increase d... | The CBD market is likely to be another strong driver for marijuana stocks. CRON Stock Cons Production: As seen with the latest earnings report, production has been lackluster for CRON, at least compared to its rivals. Bottom Line on Cronos Group Stock Even with its issues, CRON will likely remain one of the top operato... | Then what now for CRON stock? For example, during the latest quarter, the company posted revenues of only $5.6 million but the market cap was at $6 billion! True, the valuation is high and the volatility will continue, but for investors looking at the cannabis market, it does appear that the pros outweigh the cons for ... |
38535.0 | 2019-04-07 00:00:00 UTC | The 5 Largest Marijuana Deals in History | ACB | https://www.nasdaq.com/articles/5-largest-marijuana-deals-history-2019-04-07 | nan | nan | The marijuana industry is absolutely blossoming before our eyes. This year alone, according to a research report released earlier this year by Arcview Market Research and BDS Analytics, global sales should soar by 38% to $16.9 billion. This roughly $4.7 billion year-over-year improvement is the result of sales picking ... | Aurora Cannabis acquires MedReleaf: $1.98 billion As for the largest acquisition in history, that belongs to Aurora Cannabis (NYSE: ACB). Since Aurora regularly uses its common stock as a financing tool, the final price paid was just shy of $2 billion U.S. Buying MedReleaf brought three facilities into the fold. Rather... | Aurora Cannabis acquires MedReleaf: $1.98 billion As for the largest acquisition in history, that belongs to Aurora Cannabis (NYSE: ACB). With plenty of capital now on hand, Cronos can focus on pushing into overseas markets, potentially lifting its 120,000 kilos in peak annual production, and further diversifying its p... | Aurora Cannabis acquires MedReleaf: $1.98 billion As for the largest acquisition in history, that belongs to Aurora Cannabis (NYSE: ACB). Constellation Brands invests in Canopy Growth: $4 billion Without question, the largest marijuana deal in history was the equity investment from Modelo and Corona brewer Constellatio... | Aurora Cannabis acquires MedReleaf: $1.98 billion As for the largest acquisition in history, that belongs to Aurora Cannabis (NYSE: ACB). Subject to approval, Harvest Health will pay for this buyout entirely with its common stock. 10 stocks we like better than Aurora Cannabis Inc. |
38536.0 | 2019-04-07 00:00:00 UTC | Better Marijuana Stock to Buy: HEXO or Aurora Cannabis | ACB | https://www.nasdaq.com/articles/better-marijuana-stock-buy-hexo-or-aurora-cannabis-2019-04-07 | nan | nan | Canada's top marijuana producers are seeing sales soar following the country's national recreational marijuana market opening last October. Canadians illegally spend more than 5 billion Canadian dollars every year on marijuana, so the potential to profit as billions shift from the black market to licensed dispensaries ... | For instance, HEXO (NYSEMKT: HEXO) and Aurora Cannabis (NYSE: ACB) are both fast-growing cannabis companies, but one may be a smarter buy than the other. Aurora Cannabis' gross margin, or revenue after considering costs associated with marijuana production, was 52% in the fourth quarter, excluding fair-value adjustment... | For instance, HEXO (NYSEMKT: HEXO) and Aurora Cannabis (NYSE: ACB) are both fast-growing cannabis companies, but one may be a smarter buy than the other. Aurora Cannabis' net revenue was CA$54 million in the fourth quarter, up 363% year over year, including CA$47.6 million in net sales from cannabis. In its most recent... | For instance, HEXO (NYSEMKT: HEXO) and Aurora Cannabis (NYSE: ACB) are both fast-growing cannabis companies, but one may be a smarter buy than the other. Aurora Cannabis' net revenue was CA$54 million in the fourth quarter, up 363% year over year, including CA$47.6 million in net sales from cannabis. Given legal recrea... | For instance, HEXO (NYSEMKT: HEXO) and Aurora Cannabis (NYSE: ACB) are both fast-growing cannabis companies, but one may be a smarter buy than the other. Aurora Cannabis' net revenue was CA$54 million in the fourth quarter, up 363% year over year, including CA$47.6 million in net sales from cannabis. In the three month... |
38537.0 | 2019-04-07 00:00:00 UTC | 750 Million Reasons Why Aurora Cannabis Still Lags Behind Canopy Growth | ACB | https://www.nasdaq.com/articles/750-million-reasons-why-aurora-cannabis-still-lags-behind-canopy-growth-2019-04-07-0 | nan | nan | Aurora Cannabis (NYSE: ACB) is dominating Canopy Growth (NYSE: CGC) in stock performance so far this year. It's on track to beat Canopy in annual production capacity. Aurora is generating greater international sales than Canopy is.
But Aurora remains a distant second to Canopy Growth in terms of market cap. Despite Aur... | Aurora Cannabis (NYSE: ACB) is dominating Canopy Growth (NYSE: CGC) in stock performance so far this year. ACB data by YCharts . The company can easily fund its global expansion strategy thanks to a $4 billion investment last year from big alcoholic beverage maker Constellation Brands . | Aurora Cannabis (NYSE: ACB) is dominating Canopy Growth (NYSE: CGC) in stock performance so far this year. ACB data by YCharts . The two marijuana producers are running neck and neck in terms of share price performance. | Aurora Cannabis (NYSE: ACB) is dominating Canopy Growth (NYSE: CGC) in stock performance so far this year. ACB data by YCharts . Despite Aurora's outperforming its top rival in several important ways, investors don't view Aurora Cannabis in the same way they do Canopy. | Aurora Cannabis (NYSE: ACB) is dominating Canopy Growth (NYSE: CGC) in stock performance so far this year. ACB data by YCharts . Canopy Growth announced in January that it's investing between $100 million and $150 million to build a large-scale hemp production facility in the U.S. Aurora, meanwhile, hasn't made any vis... |
38538.0 | 2019-04-07 00:00:00 UTC | Which Big Canadian Marijuana Stock Has the Most Upside Potential Right Now? | ACB | https://www.nasdaq.com/articles/which-big-canadian-marijuana-stock-has-most-upside-potential-right-now-2019-04-07 | nan | nan | Can the Canadian marijuana stocks with market caps measured in the billions of dollars keep moving higher? Absolutely. It doesn't matter that they have astronomical valuations using traditional metrics. The global cannabis market is growing so rapidly that valuation measurements based on historical sales and earnings s... | How does Aphria compare against other big Canadian marijuana producers, including Aurora Cannabis (NYSE: ACB), Canopy Growth (NYSE: CGC), Cronos Group (NASDAQ: CRON), and Tilray (NASDAQ: TLRY)? It also partnered with Southern Glazer's, the biggest wine and spirits distributor in North America, to distribute its adult-u... | How does Aphria compare against other big Canadian marijuana producers, including Aurora Cannabis (NYSE: ACB), Canopy Growth (NYSE: CGC), Cronos Group (NASDAQ: CRON), and Tilray (NASDAQ: TLRY)? Top partnership candidate Canopy Growth has a big partner in Constellation Brands and received a boatload of cash from the alc... | How does Aphria compare against other big Canadian marijuana producers, including Aurora Cannabis (NYSE: ACB), Canopy Growth (NYSE: CGC), Cronos Group (NASDAQ: CRON), and Tilray (NASDAQ: TLRY)? Using this projected capacity and Aphria's current market cap, the stock's market cap-to-capacity projection is a little over ... | How does Aphria compare against other big Canadian marijuana producers, including Aurora Cannabis (NYSE: ACB), Canopy Growth (NYSE: CGC), Cronos Group (NASDAQ: CRON), and Tilray (NASDAQ: TLRY)? When it comes to how much production capacity you get per dollar invested, Aphria looks really attractive. Aphria's large prod... |
38539.0 | 2019-04-06 00:00:00 UTC | Marijuana Stock Earnings: A Comprehensive Look at First-Quarter Results | ACB | https://www.nasdaq.com/articles/marijuana-stock-earnings%3A-a-comprehensive-look-at-first-quarter-results-2019-04-06 | nan | nan | Few if any industries have the long-term growth potential of marijuana. Global sales in 2019 are expected to soar by 38%, with aggregate annual revenue potentially quintupling between 2017 and the end of the next decade to as much as $50 billion. This rapid growth is the primary reason pot stocks have been virtually un... | Furthermore, if one-time benefits and fair-value adjustments from biological assets were removed from the equation, not a single grower listed above would have even come close to a traditional profit in their most recent quarter, as evidenced by the sizable losses in the operating income/loss column above. While this m... | Different from generally accepted accounting principles (GAAP) accounting, IFRS accounting for Canadian pot growers allows these companies to constantly revalue their crops based on the stage of their growing cycle, as well as a "guestimate" of the cost to sell this product, often months before it's actually sold. As y... | With this latest quarter containing the very first recreational weed sales in Canada, all eyes were on pot stock earnings results in the first quarter. As you'll see from the aggregated quarterly operating results above, despite substantial revenue growth, popular pot stocks like Canopy Growth, Aurora Cannabis, and Til... | As you'll see from the aggregated quarterly operating results above, despite substantial revenue growth, popular pot stocks like Canopy Growth, Aurora Cannabis, and Tilray lost close to $118 million, $60 million, and $23 million, respectively, before nonrecurring benefits and expenses came into play in their most recen... |
38540.0 | 2019-04-05 00:00:00 UTC | U.S. STOCKS ON THE MOVE-Dow, Lyft, Snap, AquaBounty, Dell, Syros Pharma | ACB | https://www.nasdaq.com/articles/us-stocks-move-dow-lyft-snap-aquabounty-dell-syros-pharma-2019-04-05 | nan | nan | The Day Ahead newsletter:
The Morning News Call newsletter:
Wall Street's main indexes rose on Friday after data showed U.S. employment growth was better-than-expected in March, easing concerns of a domestic slowdown, while hopes of a U.S.-China trade deal boosted sentiment.
The top three S&P 500 percentage gainers:
**... | The Day Ahead newsletter: The Morning News Call newsletter: Wall Street's main indexes rose on Friday after data showed U.S. employment growth was better-than-expected in March, easing concerns of a domestic slowdown, while hopes of a U.S.-China trade deal boosted sentiment. The top three S&P 500 percentage gainers: **... | The Day Ahead newsletter: The Morning News Call newsletter: Wall Street's main indexes rose on Friday after data showed U.S. employment growth was better-than-expected in March, easing concerns of a domestic slowdown, while hopes of a U.S.-China trade deal boosted sentiment. The top three S&P 500 percentage gainers: **... | The Day Ahead newsletter: The Morning News Call newsletter: Wall Street's main indexes rose on Friday after data showed U.S. employment growth was better-than-expected in March, easing concerns of a domestic slowdown, while hopes of a U.S.-China trade deal boosted sentiment. The top three S&P 500 percentage gainers: **... | The Day Ahead newsletter: The Morning News Call newsletter: Wall Street's main indexes rose on Friday after data showed U.S. employment growth was better-than-expected in March, easing concerns of a domestic slowdown, while hopes of a U.S.-China trade deal boosted sentiment. The top three S&P 500 percentage gainers: **... |
38541.0 | 2019-04-05 00:00:00 UTC | Stock Market News: Boeing Takes Blame; Aurora Cannabis Gets a Win in Germany | ACB | https://www.nasdaq.com/articles/stock-market-news-boeing-takes-blame-aurora-cannabis-gets-win-germany-2019-04-05 | nan | nan | The stock market moved higher on Friday morning, buoyed by enthusiasm about the prospects for the U.S. economy to weather a slowdown following the release of solid employment numbers from the Bureau of Labor Statistics. As of 11:30 a.m. EDT, the Dow Jones Industrial Average (DJINDICES: ^DJI) was up 37 points to 26,422.... | Meanwhile, Aurora Cannabis (NYSE: ACB) looked beyond North America for growth and got a key win in its efforts to have a substantial presence in the European market. The stock market moved higher on Friday morning, buoyed by enthusiasm about the prospects for the U.S. economy to weather a slowdown following the release... | Meanwhile, Aurora Cannabis (NYSE: ACB) looked beyond North America for growth and got a key win in its efforts to have a substantial presence in the European market. The CEO said that after tireless work, Boeing is almost ready to finalize its software update to implement across the 737 MAX fleet, and although he apolo... | Meanwhile, Aurora Cannabis (NYSE: ACB) looked beyond North America for growth and got a key win in its efforts to have a substantial presence in the European market. That helped lift shares of many companies, but Boeing (NYSE: BA) wasn't one of them, as the aerospace giant took steps to work through the difficulties su... | Meanwhile, Aurora Cannabis (NYSE: ACB) looked beyond North America for growth and got a key win in its efforts to have a substantial presence in the European market. The CEO said that after tireless work, Boeing is almost ready to finalize its software update to implement across the 737 MAX fleet, and although he apolo... |
38542.0 | 2019-04-05 00:00:00 UTC | Why Aurora Cannabis Needs to Raise $750 Million | ACB | https://www.nasdaq.com/articles/why-aurora-cannabis-needs-raise-750-million-2019-04-05 | nan | nan | Canadian cannabis giant Aurora Cannabis (NYSE:) stock turned heads in early April when the company announced intentions to raise $750 million through a mixed-shelf offering over the next 25 months.
Source: Shutterstock
On the surface, it’s a bit of shocker. Aurora is one of the in the world. It’s growing very rapidly a... | Thus, the need to raise cash does raise some eyebrows, and it has created weakness in ACB stock. All in all, the shelf offering is actually good news for ACB stock. That headwind will be remedied by a capital raise, meaning ACB stock should be clear for takeoff. | Thus, the need to raise cash does raise some eyebrows, and it has created weakness in ACB stock. All in all, the shelf offering is actually good news for ACB stock. That headwind will be remedied by a capital raise, meaning ACB stock should be clear for takeoff. | Thus, the need to raise cash does raise some eyebrows, and it has created weakness in ACB stock. All in all, the shelf offering is actually good news for ACB stock. That headwind will be remedied by a capital raise, meaning ACB stock should be clear for takeoff. | That’s big news for ACB stock. Thus, the need to raise cash does raise some eyebrows, and it has created weakness in ACB stock. All in all, the shelf offering is actually good news for ACB stock. |
38543.0 | 2019-04-05 00:00:00 UTC | Pre-Market Most Active for Apr 5, 2019 : ACB, NIO, SNAP, AEG, CHK, NOK | ACB | https://www.nasdaq.com/articles/pre-market-most-active-apr-5-2019-acb-nio-snap-aeg-chk-nok-2019-04-05 | nan | nan | The NASDAQ 100 Pre-Market Indicator is up 18.98 to 7,559.55. The total Pre-Market volume is currently 3,977,388 shares traded.
The following are the most active stocks for the pre-market session :
Aurora Cannabis Inc. ( ACB ) is +0.3 at $9.25, with 631,460 shares traded. ACB's current last sale is 105.29% of the target... | The following are the most active stocks for the pre-market session : Aurora Cannabis Inc. ( ACB ) is +0.3 at $9.25, with 631,460 shares traded. ACB's current last sale is 105.29% of the target price of $8.785. Chesapeake Energy Corporation ( CHK ) is unchanged at $3.21, with 114,401 shares traded. | ACB's current last sale is 105.29% of the target price of $8.785. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. The following are the most active stocks for the pre-market session : Aurora Cannabis Inc. ( ACB ) is +0.3 at $9.25, wit... | The following are the most active stocks for the pre-market session : Aurora Cannabis Inc. ( ACB ) is +0.3 at $9.25, with 631,460 shares traded. ACB's current last sale is 105.29% of the target price of $8.785. NIO's current last sale is 76.2% of the target price of $7.1. | The following are the most active stocks for the pre-market session : Aurora Cannabis Inc. ( ACB ) is +0.3 at $9.25, with 631,460 shares traded. ACB's current last sale is 105.29% of the target price of $8.785. The NASDAQ 100 Pre-Market Indicator is up 18.98 to 7,559.55. |
38544.0 | 2019-04-05 00:00:00 UTC | U.S. STOCKS ON THE MOVE-Dow, Boston Beer, Lyft, Snap, Homebuilders | ACB | https://www.nasdaq.com/articles/us-stocks-move-dow-boston-beer-lyft-snap-homebuilders-2019-04-05 | nan | nan | The Day Ahead newsletter:
The Morning News Call newsletter:
U.S. stocks rose on Friday boosted by better-than-expected job growth in March, which eased concerns of a domestic slowdown, and hopes that the United States and China would resolve their trade dispute.
The top three S&P 500 percentage gainers:
** Apache Corp,... | The Day Ahead newsletter: The Morning News Call newsletter: U.S. stocks rose on Friday boosted by better-than-expected job growth in March, which eased concerns of a domestic slowdown, and hopes that the United States and China would resolve their trade dispute. The top three S&P 500 percentage gainers: ** Apache Corp,... | The Day Ahead newsletter: The Morning News Call newsletter: U.S. stocks rose on Friday boosted by better-than-expected job growth in March, which eased concerns of a domestic slowdown, and hopes that the United States and China would resolve their trade dispute. The top three S&P 500 percentage gainers: ** Apache Corp,... | The Day Ahead newsletter: The Morning News Call newsletter: U.S. stocks rose on Friday boosted by better-than-expected job growth in March, which eased concerns of a domestic slowdown, and hopes that the United States and China would resolve their trade dispute. The top three S&P 500 percentage gainers: ** Apache Corp,... | The Day Ahead newsletter: The Morning News Call newsletter: U.S. stocks rose on Friday boosted by better-than-expected job growth in March, which eased concerns of a domestic slowdown, and hopes that the United States and China would resolve their trade dispute. The top three S&P 500 percentage gainers: ** Apache Corp,... |
38545.0 | 2019-04-05 00:00:00 UTC | U.S. STOCKS ON THE MOVE-Dow, Lyft, Boston Beer, Trovagene | ACB | https://www.nasdaq.com/articles/us-stocks-move-dow-lyft-boston-beer-trovagene-2019-04-05 | nan | nan | The Day Ahead newsletter:
The Morning News Call newsletter:
U.S. stocks rose on Friday, boosted by better-than-expected job growth in March that eased concerns of a domestic slowdown, and hopes that the United States and China would resolve their trade dispute.
At 13:06 ET, the Dow Jones Industrial Average was up 0.05 ... | The Day Ahead newsletter: The Morning News Call newsletter: U.S. stocks rose on Friday, boosted by better-than-expected job growth in March that eased concerns of a domestic slowdown, and hopes that the United States and China would resolve their trade dispute. At 13:06 ET, the Dow Jones Industrial Average was up 0.05 ... | The Day Ahead newsletter: The Morning News Call newsletter: U.S. stocks rose on Friday, boosted by better-than-expected job growth in March that eased concerns of a domestic slowdown, and hopes that the United States and China would resolve their trade dispute. The top three S&P 500 percentage gainers: ** Apache Corp, ... | At 13:06 ET, the Dow Jones Industrial Average was up 0.05 percent at 26,398.32. The S&P 500 was up 0.33 percent at 2,888.83 and the Nasdaq Composite was up 0.50 percent at 7,931.226. The top three S&P 500 percentage gainers: ** Apache Corp, up 5.6 pct ** EOG Resources Inc, up 4.5 pct ** Anadarko Petroleum Corp, up 4.3 ... | The Day Ahead newsletter: The Morning News Call newsletter: U.S. stocks rose on Friday, boosted by better-than-expected job growth in March that eased concerns of a domestic slowdown, and hopes that the United States and China would resolve their trade dispute. At 13:06 ET, the Dow Jones Industrial Average was up 0.05 ... |
38546.0 | 2019-04-05 00:00:00 UTC | Best Performing ETFs of the First Quarter | ACB | https://www.nasdaq.com/articles/best-performing-etfs-first-quarter-2019-04-05-0 | nan | nan | In the first quarter of 2019, US stocks posted their best quarterly performance since the financial crisis. While there are still some concerns about economic growth abroad, many now see this "bad" news as "good" news on hopes of continued monetary stimulus. In fact, dovish turns by the central banks is one of the main... | Its top holdings include Aurora Cannabis ( ACB ), GW Pharmaceutical ( GWPH ) and Tilray ( TLRY ). Click to get this free report VanEck Vectors ChinaAMC SME-ChiNext ETF (CNXT): ETF Research Reports GW Pharmaceuticals PLC (GWPH): Free Stock Analysis Report Tilray, Inc. (TLRY): Free Stock Analysis Report Aurora Cannabis I... | Its top holdings include Aurora Cannabis ( ACB ), GW Pharmaceutical ( GWPH ) and Tilray ( TLRY ). Click to get this free report VanEck Vectors ChinaAMC SME-ChiNext ETF (CNXT): ETF Research Reports GW Pharmaceuticals PLC (GWPH): Free Stock Analysis Report Tilray, Inc. (TLRY): Free Stock Analysis Report Aurora Cannabis I... | Click to get this free report VanEck Vectors ChinaAMC SME-ChiNext ETF (CNXT): ETF Research Reports GW Pharmaceuticals PLC (GWPH): Free Stock Analysis Report Tilray, Inc. (TLRY): Free Stock Analysis Report Aurora Cannabis Inc. (ACB): Free Stock Analysis Report ETFMG Alternative Harvest ETF (MJ): ETF Research Reports ARK... | Click to get this free report VanEck Vectors ChinaAMC SME-ChiNext ETF (CNXT): ETF Research Reports GW Pharmaceuticals PLC (GWPH): Free Stock Analysis Report Tilray, Inc. (TLRY): Free Stock Analysis Report Aurora Cannabis Inc. (ACB): Free Stock Analysis Report ETFMG Alternative Harvest ETF (MJ): ETF Research Reports ARK... |
38547.0 | 2019-04-04 00:00:00 UTC | 10 Medical Marijuana Stocks to Cure Your Portfolio | ACB | https://www.nasdaq.com/articles/10-medical-marijuana-stocks-to-cure-your-portfolio-2019-04-04-0 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Invariably, no other investment class generates as much interest and controversy as marijuana stocks. Within a generation, public sentiment toward legalization shifted dramatically from strongly opposed to mostly supportive. This is largely due to demograph... | Aurora Cannabis (ACB) Source: Shutterstock I've spent a lot of time discussing Aurora Cannabis (NYSE: ACB ), and I don't mean to keep double-dipping into this company. Still, I keep going back for a reason: ACB stock is an excellent play within the medical-marijuana market. Furthermore, ACB stock is a strong performer. | Aurora Cannabis (ACB) Source: Shutterstock I've spent a lot of time discussing Aurora Cannabis (NYSE: ACB ), and I don't mean to keep double-dipping into this company. Still, I keep going back for a reason: ACB stock is an excellent play within the medical-marijuana market. Furthermore, ACB stock is a strong performer. | Aurora Cannabis (ACB) Source: Shutterstock I've spent a lot of time discussing Aurora Cannabis (NYSE: ACB ), and I don't mean to keep double-dipping into this company. Still, I keep going back for a reason: ACB stock is an excellent play within the medical-marijuana market. Furthermore, ACB stock is a strong performer. | Aurora Cannabis (ACB) Source: Shutterstock I've spent a lot of time discussing Aurora Cannabis (NYSE: ACB ), and I don't mean to keep double-dipping into this company. Still, I keep going back for a reason: ACB stock is an excellent play within the medical-marijuana market. Furthermore, ACB stock is a strong performer. |
38548.0 | 2019-04-04 00:00:00 UTC | 10 Medical Marijuana Stocks to Cure Your Portfolio | ACB | https://www.nasdaq.com/articles/10-medical-marijuana-stocks-to-cure-your-portfolio-2019-04-04 | nan | nan | Invariably, no other investment class generates as much interest and controversy as marijuana stocks. Within a generation, toward legalization shifted dramatically from strongly opposed to mostly supportive. This is largely due to demographics, as the more progressive millennials replace older Americans in positions of... | Aurora Cannabis (ACB) Source: Shutterstock I’ve spent a lot of time discussing Aurora Cannabis (NYSE:), and I don’t mean to keep double-dipping into this company. Still, I keep going back for a reason: ACB stock is an excellent play within the medical-marijuana market. Furthermore, ACB stock is a strong performer. | Aurora Cannabis (ACB) Source: Shutterstock I’ve spent a lot of time discussing Aurora Cannabis (NYSE:), and I don’t mean to keep double-dipping into this company. Still, I keep going back for a reason: ACB stock is an excellent play within the medical-marijuana market. Furthermore, ACB stock is a strong performer. | Aurora Cannabis (ACB) Source: Shutterstock I’ve spent a lot of time discussing Aurora Cannabis (NYSE:), and I don’t mean to keep double-dipping into this company. Still, I keep going back for a reason: ACB stock is an excellent play within the medical-marijuana market. Furthermore, ACB stock is a strong performer. | Aurora Cannabis (ACB) Source: Shutterstock I’ve spent a lot of time discussing Aurora Cannabis (NYSE:), and I don’t mean to keep double-dipping into this company. Still, I keep going back for a reason: ACB stock is an excellent play within the medical-marijuana market. Furthermore, ACB stock is a strong performer. |
38549.0 | 2019-04-04 00:00:00 UTC | Critical Levels to Watch in 3 Marijuana Stocks | ACB | https://www.nasdaq.com/articles/critical-levels-to-watch-in-3-marijuana-stocks-2019-04-04 | nan | nan | Marijuana stocks have captured the imagination of speculators. As with any industry in its infancy, the potential rewards are massive but so, too, is the risk. Today we’ll look at three of the biggest players that could prove the best marijuana stocks to play.
Uncertainty and volatility are siamese twins. Joined at the... | Critical Levels to Watch in Marijuana Stocks: Aurora Cannabis (ACB) Source: ThinkorSwim If you’re a chart watcher, Aurora Cannabis (NYSE:) should be your favorite player in the industry. You can buy ACB now or wait for a break above resistance at $9.35 to confirm the next upswing has begun. Canopy Growth Corp (CGC) Sou... | Critical Levels to Watch in Marijuana Stocks: Aurora Cannabis (ACB) Source: ThinkorSwim If you’re a chart watcher, Aurora Cannabis (NYSE:) should be your favorite player in the industry. Canopy Growth Corp (CGC) Source: ThinkorSwim Compared to ACB, the action in Canopy Growth Corp shares has been much more challenging ... | Critical Levels to Watch in Marijuana Stocks: Aurora Cannabis (ACB) Source: ThinkorSwim If you’re a chart watcher, Aurora Cannabis (NYSE:) should be your favorite player in the industry. You can buy ACB now or wait for a break above resistance at $9.35 to confirm the next upswing has begun. Canopy Growth Corp (CGC) Sou... | You can buy ACB now or wait for a break above resistance at $9.35 to confirm the next upswing has begun. Critical Levels to Watch in Marijuana Stocks: Aurora Cannabis (ACB) Source: ThinkorSwim If you’re a chart watcher, Aurora Cannabis (NYSE:) should be your favorite player in the industry. Canopy Growth Corp (CGC) Sou... |
38550.0 | 2019-04-04 00:00:00 UTC | Critical Levels to Watch in 3 Marijuana Stocks | ACB | https://www.nasdaq.com/articles/critical-levels-to-watch-in-3-marijuana-stocks-2019-04-04-0 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Marijuana stocks have captured the imagination of speculators. As with any industry in its infancy, the potential rewards are massive but so, too, is the risk. Today we'll look at three of the biggest players that could prove the best marijuana stocks to pl... | Critical Levels to Watch in Marijuana Stocks: Aurora Cannabis (ACB) Click to Enlarge Source: ThinkorSwim If you're a chart watcher, Aurora Cannabis (NYSE: ACB ) should be your favorite player in the industry. You can buy ACB now or wait for a break above resistance at $9.35 to confirm the next upswing has begun. Canopy... | Critical Levels to Watch in Marijuana Stocks: Aurora Cannabis (ACB) Click to Enlarge Source: ThinkorSwim If you're a chart watcher, Aurora Cannabis (NYSE: ACB ) should be your favorite player in the industry. Canopy Growth Corp (CGC) Click to Enlarge Source: ThinkorSwim Compared to ACB, the action in Canopy Growth Corp... | Critical Levels to Watch in Marijuana Stocks: Aurora Cannabis (ACB) Click to Enlarge Source: ThinkorSwim If you're a chart watcher, Aurora Cannabis (NYSE: ACB ) should be your favorite player in the industry. You can buy ACB now or wait for a break above resistance at $9.35 to confirm the next upswing has begun. Canopy... | You can buy ACB now or wait for a break above resistance at $9.35 to confirm the next upswing has begun. Critical Levels to Watch in Marijuana Stocks: Aurora Cannabis (ACB) Click to Enlarge Source: ThinkorSwim If you're a chart watcher, Aurora Cannabis (NYSE: ACB ) should be your favorite player in the industry. Canopy... |
38551.0 | 2019-04-04 00:00:00 UTC | Cronos Group Can't Hold a Candle to Aurora Cannabis or Canopy Growth | ACB | https://www.nasdaq.com/articles/cronos-group-cant-hold-candle-aurora-cannabis-or-canopy-growth-2019-04-04 | nan | nan | In case you missed it, something interesting happened in the marijuana industry over the past couple of weeks. Namely, Cronos Group (NASDAQ: CRON) surpassed Tilray (NASDAQ: TLRY) to become the third-largest publicly traded pot stock in the world behind only Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB).
Why... | Namely, Cronos Group (NASDAQ: CRON) surpassed Tilray (NASDAQ: TLRY) to become the third-largest publicly traded pot stock in the world behind only Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB). The $15.5 million in sales, the 20% gross margin, and the $0.33 per share loss were all less-than-desirable outcom... | Namely, Cronos Group (NASDAQ: CRON) surpassed Tilray (NASDAQ: TLRY) to become the third-largest publicly traded pot stock in the world behind only Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB). Meanwhile, around the same time as Cronos Group closed on its equity investment from Altria, Tilray reported its f... | Namely, Cronos Group (NASDAQ: CRON) surpassed Tilray (NASDAQ: TLRY) to become the third-largest publicly traded pot stock in the world behind only Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB). But let's make one thing very clear: Cronos Group can't hold a candle to Aurora Cannabis or Canopy Growth. Canopy ... | Namely, Cronos Group (NASDAQ: CRON) surpassed Tilray (NASDAQ: TLRY) to become the third-largest publicly traded pot stock in the world behind only Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB). 3 spot The lift for Cronos Group came from the closing of the $1.8 billion equity investment into the company by A... |
38552.0 | 2019-04-03 00:00:00 UTC | CannaTech Conference Series: Cam Battley, CCO Aurora Cannabis | ACB | https://www.nasdaq.com/articles/cannatech-conference-series-cam-battley-cco-aurora-cannabis-2019-04-03 | nan | nan | By The Cannabis Investing Podcast :
By Rena Sherbill
Jonathan Liss and I spent the last two days covering the CannaTech conference in Tel Aviv. We talked with a wide variety of attendees and presenters - from executives and scientists to venture capitalists, money managers, marketers and journalists. The conference end... | I was very happy to sit down on Day 2 of the conference with Cam Battley, CCO of Aurora Cannabis ( ACB ). By The Cannabis Investing Podcast : By Rena Sherbill Jonathan Liss and I spent the last two days covering the CannaTech conference in Tel Aviv. We talked with a wide variety of attendees and presenters - from execu... | I was very happy to sit down on Day 2 of the conference with Cam Battley, CCO of Aurora Cannabis ( ACB ). Cam had given an inspiring speech earlier that morning where he discussed the global medical cannabis investment landscape. See also The Case For (And Against) Owning Shares In Carriage on seekingalpha.com The view... | I was very happy to sit down on Day 2 of the conference with Cam Battley, CCO of Aurora Cannabis ( ACB ). By The Cannabis Investing Podcast : By Rena Sherbill Jonathan Liss and I spent the last two days covering the CannaTech conference in Tel Aviv. Active in more than 20 countries, Aurora produces and distributes medi... | I was very happy to sit down on Day 2 of the conference with Cam Battley, CCO of Aurora Cannabis ( ACB ). By The Cannabis Investing Podcast : By Rena Sherbill Jonathan Liss and I spent the last two days covering the CannaTech conference in Tel Aviv. Cam had given an inspiring speech earlier that morning where he discus... |
38553.0 | 2019-04-03 00:00:00 UTC | CannaTech Conference Series: Cam Battley, CCO Aurora Cannabis | ACB | https://www.nasdaq.com/articles/cannatech-conference-series-cam-battley-cco-aurora-cannabis-2019-04-03-0 | nan | nan | By The Cannabis Investing Podcast :
By Rena Sherbill
Jonathan Liss and I spent the last two days covering the CannaTech conference in Tel Aviv. We talked with a wide variety of attendees and presenters - from executives and scientists to venture capitalists, money managers, marketers and journalists. The conference end... | I was very happy to sit down on Day 2 of the conference with Cam Battley, CCO of Aurora Cannabis ( ACB ). By The Cannabis Investing Podcast : By Rena Sherbill Jonathan Liss and I spent the last two days covering the CannaTech conference in Tel Aviv. We talked with a wide variety of attendees and presenters - from execu... | I was very happy to sit down on Day 2 of the conference with Cam Battley, CCO of Aurora Cannabis ( ACB ). Cam had given an inspiring speech earlier that morning where he discussed the global medical cannabis investment landscape. See also Fitbit's Turnaround Is Real And It's Mostly Apple's Fault on seekingalpha.com The... | I was very happy to sit down on Day 2 of the conference with Cam Battley, CCO of Aurora Cannabis ( ACB ). By The Cannabis Investing Podcast : By Rena Sherbill Jonathan Liss and I spent the last two days covering the CannaTech conference in Tel Aviv. Active in more than 20 countries, Aurora produces and distributes medi... | I was very happy to sit down on Day 2 of the conference with Cam Battley, CCO of Aurora Cannabis ( ACB ). By The Cannabis Investing Podcast : By Rena Sherbill Jonathan Liss and I spent the last two days covering the CannaTech conference in Tel Aviv. Cam had given an inspiring speech earlier that morning where he discus... |
38554.0 | 2019-04-03 00:00:00 UTC | Pre-Market Most Active for Apr 3, 2019 : AMD, APTX, BABA, ACB, MFGP, GME, BCS, NIO, SQQQ, QQQ, ADXS, BILI | ACB | https://www.nasdaq.com/articles/pre-market-most-active-apr-3-2019-amd-aptx-baba-acb-mfgp-gme-bcs-nio-sqqq-qqq-adxs-bili | nan | nan | The NASDAQ 100 Pre-Market Indicator is up 26.94 to 7,526.58. The total Pre-Market volume is currently 9,318,806 shares traded.
The following are the most active stocks for the pre-market session :
Advanced Micro Devices, Inc. ( AMD ) is +1.33 at $28.08, with 1,803,453 shares traded. AMD's current last sale is 100.29% o... | Aurora Cannabis Inc. ( ACB ) is -0.28 at $8.79, with 601,786 shares traded. ACB's current last sale is 100.06% of the target price of $8.785. The following are the most active stocks for the pre-market session : Advanced Micro Devices, Inc. ( AMD ) is +1.33 at $28.08, with 1,803,453 shares traded. | Aurora Cannabis Inc. ( ACB ) is -0.28 at $8.79, with 601,786 shares traded. ACB's current last sale is 100.06% of the target price of $8.785. Micro Focus Intl PLC ( MFGP ) is +0.11 at $26.86, with 502,287 shares traded., following a 52-week high recorded in prior regular session. | Aurora Cannabis Inc. ( ACB ) is -0.28 at $8.79, with 601,786 shares traded. ACB's current last sale is 100.06% of the target price of $8.785. The total Pre-Market volume is currently 9,318,806 shares traded. | Aurora Cannabis Inc. ( ACB ) is -0.28 at $8.79, with 601,786 shares traded. ACB's current last sale is 100.06% of the target price of $8.785. The NASDAQ 100 Pre-Market Indicator is up 26.94 to 7,526.58. |
38555.0 | 2019-04-03 00:00:00 UTC | Why Aurora Cannabis Outperformed Canopy Growth and Tilray in Q1 | ACB | https://www.nasdaq.com/articles/why-aurora-cannabis-outperformed-canopy-growth-and-tilray-q1-2019-04-03 | nan | nan | Canadian marijuana stocks, in general, delivered sizzling performances in the first quarter of this year. Many stocks generated greater returns in the quarter than they did in all of 2018.
Among the biggest players in the cannabis industry, there was one clear winner. Aurora Cannabis (NYSE: ACB) handily outperformed bo... | Aurora Cannabis (NYSE: ACB) handily outperformed both Canopy Growth (NYSE: CGC) and Tilray (NASDAQ: TLRY). Peltz, the founder and CEO of multibillion-dollar investment firm Trian Fund Management, claims extensive ties in the consumer goods industry. The news that Peltz will actively seek partners for Aurora in industri... | Aurora Cannabis (NYSE: ACB) handily outperformed both Canopy Growth (NYSE: CGC) and Tilray (NASDAQ: TLRY). Despite its lower market cap, though, Aurora's production capacity is much greater than Tilray's. Increased optimism about partnerships Aurora Cannabis gained nearly 83% in the first quarter versus 61% for Canopy ... | Aurora Cannabis (NYSE: ACB) handily outperformed both Canopy Growth (NYSE: CGC) and Tilray (NASDAQ: TLRY). Increased optimism about partnerships Aurora Cannabis gained nearly 83% in the first quarter versus 61% for Canopy Growth and a 7% decline for Tilray. Aurora Cannabis claimed a 20% market share in the Canadian adu... | Aurora Cannabis (NYSE: ACB) handily outperformed both Canopy Growth (NYSE: CGC) and Tilray (NASDAQ: TLRY). But for much of the quarter, Canopy Growth was ahead of Aurora. Aurora Cannabis claimed a 20% market share in the Canadian adult-use marijuana market. |
38556.0 | 2019-04-02 00:00:00 UTC | Canada's Top 11 Marijuana Growers Have Reshuffled Again | ACB | https://www.nasdaq.com/articles/canadas-top-11-marijuana-growers-have-reshuffled-again-2019-04-02 | nan | nan | The marijuana industry is budding before our eyes, but blink and you might miss a big development.
Arguably the most fluid aspect of the cannabis industry has been the constant updating and reshuffling of marijuana production. Growers have been in a pretty steady escalation battle with one another for more than a year ... | Aurora Cannabis: Approximately 700,000 kilos Absolutely no surprise here, with Aurora Cannabis (NYSE: ACB) easily maintaining its pole position in terms of production. Not only should this allow Canopy Growth to produce at least 500,000 kilos annually at average industry yields, but its ability to secure cultivation li... | Aurora Cannabis: Approximately 700,000 kilos Absolutely no surprise here, with Aurora Cannabis (NYSE: ACB) easily maintaining its pole position in terms of production. Following a recent acquisition by HEXO (NYSEMKT: HEXO), as well as upped production forecasts from The Green Organic Dutchman (NASDAQOTH: TGODF) and Can... | Aurora Cannabis: Approximately 700,000 kilos Absolutely no surprise here, with Aurora Cannabis (NYSE: ACB) easily maintaining its pole position in terms of production. With its recent fourth-quarter earnings release, the company guided to 100,000 kilos, in aggregate, once its phase 3 expansion (spanning 390,000 square ... | Aurora Cannabis: Approximately 700,000 kilos Absolutely no surprise here, with Aurora Cannabis (NYSE: ACB) easily maintaining its pole position in terms of production. Both projects are expected to yield 110,000 kilos and 140,000 kilos at peak annual output. Tilray: Greater than 100,000 kilos Previously, I had Tilray o... |
38557.0 | 2019-04-01 00:00:00 UTC | Marijuana Stocks Look Frothy, But Aurora Stock Is Well-Prepared | ACB | https://www.nasdaq.com/articles/marijuana-stocks-look-frothy-aurora-stock-well-prepared-2019-04-01 | nan | nan | Over the long run, I remain net bullish on legal marijuana. However, my optimism for the sector doesn’t cloud reality. I can see as plain as daylight that the honeymoon phase is over. Now, companies like Aurora Cannabis (NYSE:) must provide the goods. If not, ACB stock could face serious trouble.
Source: Shutterstock
U... | Understandably, stakeholders and prospective buyers in ACB stock want a clearer and more consistent picture before diving into Aurora shares. To put that into context, ACB’s only real rival in this space is Canopy Growth (NYSE:), which forecasts similar figures. If not, ACB stock could face serious trouble. | Multi-Layered Tailwinds Boost ACB Stock Whenever anyone discusses Aurora Cannabis stock, one of the top bullet points is production capacity. If not, ACB stock could face serious trouble. Not only that, ACB is one of few publicly traded cannabis firms that has generated shareholder profits every month thus far. | Understandably, stakeholders and prospective buyers in ACB stock want a clearer and more consistent picture before diving into Aurora shares. Multi-Layered Tailwinds Boost ACB Stock Whenever anyone discusses Aurora Cannabis stock, one of the top bullet points is production capacity. Don’t Shy Away From ACB Stock Despit... | Multi-Layered Tailwinds Boost ACB Stock Whenever anyone discusses Aurora Cannabis stock, one of the top bullet points is production capacity. If not, ACB stock could face serious trouble. Not only that, ACB is one of few publicly traded cannabis firms that has generated shareholder profits every month thus far. |
38558.0 | 2019-04-01 00:00:00 UTC | Is Marijuana Stock CannTrust Underselling Its Future Pot Production? | ACB | https://www.nasdaq.com/articles/marijuana-stock-canntrust-underselling-its-future-pot-production-2019-04-01 | nan | nan | CannTrust Holdings (NYSE: CTST) recently completed a greenhouse expansion that should boost its annual marijuana production to 50,000 kilos this year and another that's on track to increase its annualized production capacity to 100,000 kilos by the end of 2020. Additionally, management disclosed Thursday it's signed a ... | How CannTrust could catch up Canopy Growth, Aurora Cannabis (NYSE: ACB), and Aphria (NYSE: APHA) are Canada's three biggest pot stocks by sales. Canada's cannabis market is worth approximately 6 billion Canadian dollars per year and only about CA$600 million of that was spent legally on medical marijuana there in 2018.... | How CannTrust could catch up Canopy Growth, Aurora Cannabis (NYSE: ACB), and Aphria (NYSE: APHA) are Canada's three biggest pot stocks by sales. Canada's cannabis market is worth approximately 6 billion Canadian dollars per year and only about CA$600 million of that was spent legally on medical marijuana there in 2018.... | How CannTrust could catch up Canopy Growth, Aurora Cannabis (NYSE: ACB), and Aphria (NYSE: APHA) are Canada's three biggest pot stocks by sales. CannTrust Holdings (NYSE: CTST) recently completed a greenhouse expansion that should boost its annual marijuana production to 50,000 kilos this year and another that's on tra... | How CannTrust could catch up Canopy Growth, Aurora Cannabis (NYSE: ACB), and Aphria (NYSE: APHA) are Canada's three biggest pot stocks by sales. CannTrust Holdings (NYSE: CTST) recently completed a greenhouse expansion that should boost its annual marijuana production to 50,000 kilos this year and another that's on tra... |
38559.0 | 2019-04-01 00:00:00 UTC | Pre-Market Most Active for Apr 1, 2019 : TAK, SQQQ, AMD, NIO, SELB, ACB, ADXS, TQQQ, QQQ, T, GE, SWI | ACB | https://www.nasdaq.com/articles/pre-market-most-active-apr-1-2019-tak-sqqq-amd-nio-selb-acb-adxs-tqqq-qqq-t-ge-swi-2019-04 | nan | nan | The NASDAQ 100 Pre-Market Indicator is up 53.41 to 7,432.18. The total Pre-Market volume is currently 5,858,152 shares traded.
The following are the most active stocks for the pre-market session :
Takeda Pharmaceutical Company Limited ( TAK ) is +0.2938 at $20.66, with 2,829,400 shares traded. As reported by Zacks, the... | Aurora Cannabis Inc. ( ACB ) is +0.2 at $9.26, with 315,348 shares traded. ACB's current last sale is 105.41% of the target price of $8.785. The following are the most active stocks for the pre-market session : Takeda Pharmaceutical Company Limited ( TAK ) is +0.2938 at $20.66, with 2,829,400 shares traded. | Aurora Cannabis Inc. ( ACB ) is +0.2 at $9.26, with 315,348 shares traded. ACB's current last sale is 105.41% of the target price of $8.785. As reported by Zacks, the current mean recommendation for TAK is in the "strong buy range". | Aurora Cannabis Inc. ( ACB ) is +0.2 at $9.26, with 315,348 shares traded. ACB's current last sale is 105.41% of the target price of $8.785. NIO Inc. ( NIO ) is +0.16 at $5.26, with 437,767 shares traded. | Aurora Cannabis Inc. ( ACB ) is +0.2 at $9.26, with 315,348 shares traded. ACB's current last sale is 105.41% of the target price of $8.785. The NASDAQ 100 Pre-Market Indicator is up 53.41 to 7,432.18. |
38560.0 | 2019-04-01 00:00:00 UTC | This Popular Pot Stock Doesn't Need a Partner or Buyout, CEO Says | ACB | https://www.nasdaq.com/articles/popular-pot-stock-doesnt-need-partner-or-buyout-ceo-says-2019-04-01 | nan | nan | If you're looking for the fastest-growing industries on the planet, there's a good chance your research is going to lead you to the marijuana industry. Depending on which Wall Street estimate you prefer, the legal weed industry could grow to as large as $50 billion to $75 billion in about a decade's time. That's enormo... | Among the popular pot stocks, only Aurora Cannabis (NYSE: ACB) and Aphria are currently without a brand-name partner. As a company with top-tier production, the expectation is that Aphria would have no trouble securing lucrative long-term supply deals, as well as attracting brand-name partners in the food, beverage, to... | Among the popular pot stocks, only Aurora Cannabis (NYSE: ACB) and Aphria are currently without a brand-name partner. By comparison, Canopy Growth is lugging around a $15 billion market cap for just over 500,000 kilos in peak annual production, while Cronos Group sports a $3.4 billion market cap for only 120,000 kilos ... | Among the popular pot stocks, only Aurora Cannabis (NYSE: ACB) and Aphria are currently without a brand-name partner. Putting profitability aside for the moment, since legal weed is such a new industry, investors can purchase Aphria's 255,000 kilos of peak output for a market cap of $2.3 billion. Also, with about 10% o... | Among the popular pot stocks, only Aurora Cannabis (NYSE: ACB) and Aphria are currently without a brand-name partner. What's next for Aphria? 10 stocks we like better than Aphria Inc. |
38561.0 | 2019-04-01 00:00:00 UTC | Aurora Cannabis Inc. (ACB) Outpaces Stock Market Gains: What You Should Know | ACB | https://www.nasdaq.com/articles/aurora-cannabis-inc.-acb-outpaces-stock-market-gains%3A-what-you-should-know-2019-04-01-0 | nan | nan | In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $9.18, marking a +1.32% move from the previous day. This change outpaced the S&P 500's 1.16% gain on the day. Meanwhile, the Dow gained 1.27%, and the Nasdaq, a tech-heavy index, added 1.29%.
Heading into today, shares of the company had gained 19.84% ... | In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $9.18, marking a +1.32% move from the previous day. Investors will be hoping for strength from ACB as it approaches its nex t earnings release. In tha t report , analysts expect ACB to post earnings of -$0.05 per share. | In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $9.18, marking a +1.32% move from the previous day. Click to get this free report Aurora Cannabis Inc. (ACB): Free Stock Analysis Report To read this article on Zacks.com click here. Investors will be hoping for strength from ACB as it approaches its n... | In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $9.18, marking a +1.32% move from the previous day. Investors will be hoping for strength from ACB as it approaches its nex t earnings release. In tha t report , analysts expect ACB to post earnings of -$0.05 per share. | In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $9.18, marking a +1.32% move from the previous day. Investors will be hoping for strength from ACB as it approaches its nex t earnings release. In tha t report , analysts expect ACB to post earnings of -$0.05 per share. |
38562.0 | 2019-03-31 00:00:00 UTC | 4 Reasons Medical Marijuana Stocks Are a Smarter Play Than Recreational Pot Stocks | ACB | https://www.nasdaq.com/articles/4-reasons-medical-marijuana-stocks-are-smarter-play-recreational-pot-stocks-2019-03-31 | nan | nan | The marijuana industry has been practically unstoppable in recent years, with that momentum carrying over into 2019. Through the first three months of the year, the broad-based Horizons Marijuana Life Sciences ETF has risen by approximately 60%.
According to Wall Street investment banks, this is an industry forecast to... | Aurora Cannabis (NYSE: ACB), the forecast largest grower by peak yield, noted in its second-quarter operating results press release that it would be turning its attention to the medical marijuana market. The ongoing ramp-up of production from growers, packaging shortages, and regulatory red tape associated with Health ... | Aurora Cannabis (NYSE: ACB), the forecast largest grower by peak yield, noted in its second-quarter operating results press release that it would be turning its attention to the medical marijuana market. According to Wall Street investment banks, this is an industry forecast to grow at a double-digit annual pace for ye... | Aurora Cannabis (NYSE: ACB), the forecast largest grower by peak yield, noted in its second-quarter operating results press release that it would be turning its attention to the medical marijuana market. Four reasons medical marijuana stocks deserve your attention Even though the recreational market is projected to tow... | Aurora Cannabis (NYSE: ACB), the forecast largest grower by peak yield, noted in its second-quarter operating results press release that it would be turning its attention to the medical marijuana market. Four reasons medical marijuana stocks deserve your attention Even though the recreational market is projected to tow... |
38563.0 | 2019-03-31 00:00:00 UTC | Which Canadian Marijuana Stock Is Best Poised to Win in the U.S.: Aurora Cannabis, Cronos, Canopy Growth, or Tilray? | ACB | https://www.nasdaq.com/articles/which-canadian-marijuana-stock-best-poised-win-us-aurora-cannabis-cronos-canopy-growth-or | nan | nan | Canada's recreational marijuana market and European medical cannabis markets tend to be the top subjects of discussion for executives of the biggest marijuana producers. That makes sense, with nearly all of the revenue for the big marijuana companies being generated in Canada and in Europe.
But what about the U.S., the... | The biggest of those big marijuana producers in terms of market cap -- Canopy Growth (NYSE: CGC), Aurora Cannabis (NYSE: ACB), Tilray (NASDAQ: TLRY), and Cronos Group (NASDAQ: CRON) -- can't enter the U.S. marijuana market and retain their listings on major stock exchanges as long as marijuana remains illegal at the fe... | The biggest of those big marijuana producers in terms of market cap -- Canopy Growth (NYSE: CGC), Aurora Cannabis (NYSE: ACB), Tilray (NASDAQ: TLRY), and Cronos Group (NASDAQ: CRON) -- can't enter the U.S. marijuana market and retain their listings on major stock exchanges as long as marijuana remains illegal at the fe... | The biggest of those big marijuana producers in terms of market cap -- Canopy Growth (NYSE: CGC), Aurora Cannabis (NYSE: ACB), Tilray (NASDAQ: TLRY), and Cronos Group (NASDAQ: CRON) -- can't enter the U.S. marijuana market and retain their listings on major stock exchanges as long as marijuana remains illegal at the fe... | The biggest of those big marijuana producers in terms of market cap -- Canopy Growth (NYSE: CGC), Aurora Cannabis (NYSE: ACB), Tilray (NASDAQ: TLRY), and Cronos Group (NASDAQ: CRON) -- can't enter the U.S. marijuana market and retain their listings on major stock exchanges as long as marijuana remains illegal at the fe... |
38564.0 | 2019-03-31 00:00:00 UTC | Better Marijuana Stock to Buy: Tilray or Aurora Cannabis | ACB | https://www.nasdaq.com/articles/better-marijuana-stock-buy-tilray-or-aurora-cannabis-2019-03-31 | nan | nan | Sales at top marijuana producers are soaring following the opening of Canada's recreational marijuana market last October. Billions of dollars are expected to shift from the black market to licensed retailers over the coming years, so we're still only in the early innings for this industry. There are lots of marijuana ... | For instance, Tilray (NASDAQ: TLRY) and Aurora Cannabis (NYSE: ACB) are two of the largest pot stocks by market cap, but I think only one of them is worthy of consideration right now. The shortages should be a temporary headwind to legal adult-use sales in Canada, because cannabis companies are investing furiously to b... | For instance, Tilray (NASDAQ: TLRY) and Aurora Cannabis (NYSE: ACB) are two of the largest pot stocks by market cap, but I think only one of them is worthy of consideration right now. Operating expenses outstripped revenue causing both companies to report big net losses last quarter. Aurora's net loss was a CA$238 mill... | For instance, Tilray (NASDAQ: TLRY) and Aurora Cannabis (NYSE: ACB) are two of the largest pot stocks by market cap, but I think only one of them is worthy of consideration right now. Cashing in on cannabis Tilray and Aurora Cannabis are among the most widely owned marijuana stocks. In fact, although Aurora Cannabis' f... | For instance, Tilray (NASDAQ: TLRY) and Aurora Cannabis (NYSE: ACB) are two of the largest pot stocks by market cap, but I think only one of them is worthy of consideration right now. Nevertheless, Canada reported that recreational sales still topped $150 million Canadian last quarter, which just about matched legal me... |
38565.0 | 2019-03-30 00:00:00 UTC | Canadian Recreational Pot Market: How the Big 5 Marijuana Growers Compare | ACB | https://www.nasdaq.com/articles/canadian-recreational-pot-market-how-big-5-marijuana-growers-compare-2019-03-30 | nan | nan | Nearly everyone expected sales to soar for the biggest marijuana producers after Canada's recreational marijuana market opened on Oct. 17, 2018. And that's exactly what happened.
The five biggest Canadian marijuana growers by market cap -- Canopy Growth (NYSE: CGC), Aurora Cannabis (NYSE: ACB), Tilray (NASDAQ: TLRY), C... | The five biggest Canadian marijuana growers by market cap -- Canopy Growth (NYSE: CGC), Aurora Cannabis (NYSE: ACB), Tilray (NASDAQ: TLRY), Cronos Group (NASDAQ: CRON), and Aphria (NYSE: APHA) -- have all reported their first quarterly updates that include sales to the recreational pot market in Canada. However, the co... | The five biggest Canadian marijuana growers by market cap -- Canopy Growth (NYSE: CGC), Aurora Cannabis (NYSE: ACB), Tilray (NASDAQ: TLRY), Cronos Group (NASDAQ: CRON), and Aphria (NYSE: APHA) -- have all reported their first quarterly updates that include sales to the recreational pot market in Canada. Aurora and Cano... | The five biggest Canadian marijuana growers by market cap -- Canopy Growth (NYSE: CGC), Aurora Cannabis (NYSE: ACB), Tilray (NASDAQ: TLRY), Cronos Group (NASDAQ: CRON), and Aphria (NYSE: APHA) -- have all reported their first quarterly updates that include sales to the recreational pot market in Canada. Cronos and Tilr... | The five biggest Canadian marijuana growers by market cap -- Canopy Growth (NYSE: CGC), Aurora Cannabis (NYSE: ACB), Tilray (NASDAQ: TLRY), Cronos Group (NASDAQ: CRON), and Aphria (NYSE: APHA) -- have all reported their first quarterly updates that include sales to the recreational pot market in Canada. Nearly everyone... |
38566.0 | 2019-03-30 00:00:00 UTC | 5 Off-the-Cuff Thoughts About the Marijuana Industry | ACB | https://www.nasdaq.com/articles/5-cuff-thoughts-about-marijuana-industry-2019-03-30 | nan | nan | According to a handful of Wall Street investment firms, the marijuana industry is slated to grow by leaps and bounds over the next decade. Depending on your preferred source, annual global sales could hit $75 billion by 2030, placing the industry on par with, or perhaps even ahead of, worldwide soda sales.
It's also an... | Investors are absolutely enamored with Aurora Cannabis (NYSE: ACB), which purchased CanniMed Therapeutics for $852 million, MedReleaf for about $2 billion, ICC Labs for $200 million, and Whistler Medical Marijuana for approximately $130 million over the past year. OrganiGram's location in New Brunswick gives the compan... | Investors are absolutely enamored with Aurora Cannabis (NYSE: ACB), which purchased CanniMed Therapeutics for $852 million, MedReleaf for about $2 billion, ICC Labs for $200 million, and Whistler Medical Marijuana for approximately $130 million over the past year. Most acquiring pot stocks are grossly overpaying for th... | Investors are absolutely enamored with Aurora Cannabis (NYSE: ACB), which purchased CanniMed Therapeutics for $852 million, MedReleaf for about $2 billion, ICC Labs for $200 million, and Whistler Medical Marijuana for approximately $130 million over the past year. Every high-growth industry has had its bubble burst ove... | Investors are absolutely enamored with Aurora Cannabis (NYSE: ACB), which purchased CanniMed Therapeutics for $852 million, MedReleaf for about $2 billion, ICC Labs for $200 million, and Whistler Medical Marijuana for approximately $130 million over the past year. Every high-growth industry has had its bubble burst ove... |
38567.0 | 2019-03-30 00:00:00 UTC | Down 19.7%, Is CannTrust Holdings Stock Now a Bargain? | ACB | https://www.nasdaq.com/articles/down-197-canntrust-holdings-stock-now-bargain-2019-03-30 | nan | nan | Last week, Canadian pot company CannTrust Holdings (NYSE: CTST) lost nearly 20% of its value after reporting fourth-quarter earnings on Thursday. The fly in the ointment, so to speak, was the company's disappointing revenue haul of CA$16.2 million (roughly $12.1 million at current exchange rates) over the course of Q4,... | According to the report, CannTrust has entered into letters of intent to secure an additional 200 acres of land slated for a massive outdoor grow facility. Apart from this dramatic increase in production capacity, CannTrust should also benefit from the tremendous cost-savings that comes with outdoor grows, compared to ... | Last week, Canadian pot company CannTrust Holdings (NYSE: CTST) lost nearly 20% of its value after reporting fourth-quarter earnings on Thursday. Like most pot companies not named Aurora Cannabis, Canopy Growth, or Cronos Group, CannTrust is in a bit a of bind. A total peak annual output of 200,000 kg would put CannTru... | A total peak annual output of 200,000 kg would put CannTrust into the top six Canadian producers overall; a 300,000 kg annual haul, on the other hand, would catapult the company solidly into third place -- behind only Aurora and Canopy Growth in terms of peak cultivation capacity. CannTrust, in turn, shouldn't need to ... | Last week, Canadian pot company CannTrust Holdings (NYSE: CTST) lost nearly 20% of its value after reporting fourth-quarter earnings on Thursday. Plus, the company's decision to jump into the outdoor growth game could provide significant cost-savings and help lower the impact of falling profit margins across the indust... |
38568.0 | 2019-03-29 00:00:00 UTC | Cronos Group Is the Most Overvalued Pot Stock and Its Quarterly Report Proves It | ACB | https://www.nasdaq.com/articles/cronos-group-most-overvalued-pot-stock-and-its-quarterly-report-proves-it-2019-03-29 | nan | nan | The marijuana industry has been blazing hot to begin 2019, and perhaps no pot stock with a valuation of more than $1 billion has been hotter than Cronos Group (NASDAQ: CRON). Shares of the Ontario-based grower have more than doubled since early December, which is when the company announced that it was receiving a $1.8 ... | By comparison, Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC), the projected two largest producers by peak annual output, reported net fourth-quarter revenue (i.e., gross sales less excise tax) of CA$54.2 million ($40.5 million) and CA$83 million ($62 million), respectively. The marijuana industry has been b... | By comparison, Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC), the projected two largest producers by peak annual output, reported net fourth-quarter revenue (i.e., gross sales less excise tax) of CA$54.2 million ($40.5 million) and CA$83 million ($62 million), respectively. This confirms it: Cronos is gross... | By comparison, Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC), the projected two largest producers by peak annual output, reported net fourth-quarter revenue (i.e., gross sales less excise tax) of CA$54.2 million ($40.5 million) and CA$83 million ($62 million), respectively. The company ended 2018 with "only... | By comparison, Aurora Cannabis (NYSE: ACB) and Canopy Growth (NYSE: CGC), the projected two largest producers by peak annual output, reported net fourth-quarter revenue (i.e., gross sales less excise tax) of CA$54.2 million ($40.5 million) and CA$83 million ($62 million), respectively. This confirms it: Cronos is gross... |
38569.0 | 2019-03-28 00:00:00 UTC | 2 Pros and 3 Big Cons to Owning Aurora Cannabis Stock Now | ACB | https://www.nasdaq.com/articles/2-pros-and-3-big-cons-owning-aurora-cannabis-stock-now-2019-03-28 | nan | nan | For Canadian cannabis producer Aurora Cannabis (NYSE:), the last few years or so have been wonderful, to say the least. ACB stock is up more than 75% this year and it is up more than 700% in the last five years. That’s some pretty torrid growth, which underscores the potential of legalized marijuana.
Source: Shuttersto... | ACB stock is up more than 75% this year and it is up more than 700% in the last five years. But ACB does have some warts as well. The question for investors is whether the pros outweigh the cons with ACB stock. | ACB stock is up more than 75% this year and it is up more than 700% in the last five years. But ACB does have some warts as well. The question for investors is whether the pros outweigh the cons with ACB stock. | ACB’s Three Major Cons ACB Is a Share Dilution Machine: One of the biggest hits for Aurora Cannabis has to be its continued issuance of shares. ACB Stock May Still Be a Buy For investors looking at the marijuana sector, Aurora Cannabis stock has a lot to offer portfolios. ACB stock is up more than 75% this year and it ... | That’s just what ACB has done. Given ACB’s share dilution, this could be a big problem later on. ACB stock is up more than 75% this year and it is up more than 700% in the last five years. |
38570.0 | 2019-03-28 00:00:00 UTC | Forget Aurora Cannabis and Buy These 3 Pot Stocks Instead | ACB | https://www.nasdaq.com/articles/forget-aurora-cannabis-and-buy-these-3-pot-stocks-instead-2019-03-28 | nan | nan | The marijuana industry is on fire, and it's not hard to understand why. According to a handful of Wall Street investment banks, the legal weed industry is on track for as much as $50 billion to $75 billion in global annual sales by the end of the next decade. That'd place the cannabis industry more or less on par with ... | The market's most popular pot stock Arguably no company has been more popular with investors -- especially millennial investors -- than Aurora Cannabis (NYSE: ACB). Namely, in order to fund organic build-outs, joint venture greenhouse retrofits, and its numerous acquisitions, Aurora has issued more than 1 billion share... | The market's most popular pot stock Arguably no company has been more popular with investors -- especially millennial investors -- than Aurora Cannabis (NYSE: ACB). KushCo Holdings In the ancillary niche, KushCo Holdings (NASDAQOTH: KSHB) looks to be a much smarter and cheaper way to play the cannabis space than Aurora... | The market's most popular pot stock Arguably no company has been more popular with investors -- especially millennial investors -- than Aurora Cannabis (NYSE: ACB). KushCo Holdings In the ancillary niche, KushCo Holdings (NASDAQOTH: KSHB) looks to be a much smarter and cheaper way to play the cannabis space than Aurora... | The market's most popular pot stock Arguably no company has been more popular with investors -- especially millennial investors -- than Aurora Cannabis (NYSE: ACB). Charlotte's Web Holdings A third pot stock to consider buying instead of Aurora Cannabis is Charlotte's Web Holdings (NASDAQOTH: CWBHF). In 2017, and throu... |
38571.0 | 2019-03-27 00:00:00 UTC | Pre-Market Most Active for Mar 27, 2019 : VEON, AEG, NIO, SAN, SQQQ, TVIX, AMD, SE, CNC, QQQ, AXSM, ACB | ACB | https://www.nasdaq.com/articles/pre-market-most-active-mar-27-2019-veon-aeg-nio-san-sqqq-tvix-amd-se-cnc-qqq-axsm-acb-2019 | nan | nan | The NASDAQ 100 Pre-Market Indicator is up 8.33 to 7,359.48. The total Pre-Market volume is currently 10,980,646 shares traded.
The following are the most active stocks for the pre-market session :
VEON Ltd. ( VEON ) is -0.16 at $2.19, with 8,284,707 shares traded. VEON's current last sale is 65.37% of the target price ... | Aurora Cannabis Inc. ( ACB ) is -0.1299 at $9.03, with 163,456 shares traded. ACB's current last sale is 102.79% of the target price of $8.785. ProShares UltraPro Short QQQ ( SQQQ ) is +0.05 at $10.32, with 239,129 shares traded. | The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Aurora Cannabis Inc. ( ACB ) is -0.1299 at $9.03, with 163,456 shares traded. ACB's current last sale is 102.79% of the target price of $8.785. | Aurora Cannabis Inc. ( ACB ) is -0.1299 at $9.03, with 163,456 shares traded. ACB's current last sale is 102.79% of the target price of $8.785. The total Pre-Market volume is currently 10,980,646 shares traded. | Aurora Cannabis Inc. ( ACB ) is -0.1299 at $9.03, with 163,456 shares traded. ACB's current last sale is 102.79% of the target price of $8.785. The NASDAQ 100 Pre-Market Indicator is up 8.33 to 7,359.48. |
38572.0 | 2019-03-27 00:00:00 UTC | Canopy Growth Stock Is Stuck — Is It Finally Ready to Break Out? | ACB | https://www.nasdaq.com/articles/canopy-growth-stock-stuck-it-finally-ready-break-out-2019-03-27 | nan | nan | From mid-December to late January, Canopy Growth (NYSE:) stock staged an impressive rally, going from $26 to $48. But since then, the bullishness has cooled off. Canopy Growth stock has essentially been in a trading range of $44 to $48.
Source: Shutterstock
This should not necessarily be a surprise, though. Of course, ... | But interestingly enough, it looks like another market is about to open up in a big way and should be a nice driver for CGC stock: Cannabidiol (CBD). For example, the company recently entered a deal with Martha Stewart’s Sequential Brands Group, so as to create CBD remedies for pets. And while there will certainly be v... | From mid-December to late January, Canopy Growth (NYSE:) stock staged an impressive rally, going from $26 to $48. Bottom Line on CGC Stock During the past year, we have gotten more choices — like Cronos (NASDAQ:), Tilray (NASDAQ:) and Aurora Cannabis (NYSE:) — to invest in the cannabis market. And while there will cert... | As for CGC, the company has been investing in its CBD business for some time. Bottom Line on CGC Stock During the past year, we have gotten more choices — like Cronos (NASDAQ:), Tilray (NASDAQ:) and Aurora Cannabis (NYSE:) — to invest in the cannabis market. And while there will certainly be volatility, which is natura... | As for CGC, the company has been investing in its CBD business for some time. But among the cannabis stocks, CGC really does stand out. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. |
38573.0 | 2019-03-27 00:00:00 UTC | Which Pot Stock -- Aurora, Canopy, Tilray, or Cronos -- Will Be Profitable Last? | ACB | https://www.nasdaq.com/articles/which-pot-stock-aurora-canopy-tilray-or-cronos-will-be-profitable-last-2019-03-27 | nan | nan | When it comes to growth, no industry is expected to pile on the green, at least from a revenue perspective, more than legal cannabis. This year alone, global weed sales are expected to grow from an estimated $12.2 billion to $16.9 billion (that's 38% for those of you keeping score at home), according to Arcview Market ... | This is especially true of the four most popular marijuana stocks -- Aurora Cannabis (NYSE: ACB) , Canopy Growth (NYSE: CGC) , Tilray (NASDAQ: TLRY) , and Cronos Group (NASDAQ: CRON) -- which have lost a staggering amount of money, combined, on an operating basis. In the company's second-quarter operating results press... | This is especially true of the four most popular marijuana stocks -- Aurora Cannabis (NYSE: ACB) , Canopy Growth (NYSE: CGC) , Tilray (NASDAQ: TLRY) , and Cronos Group (NASDAQ: CRON) -- which have lost a staggering amount of money, combined, on an operating basis. Profitability may be around the corner for Canada's big... | This is especially true of the four most popular marijuana stocks -- Aurora Cannabis (NYSE: ACB) , Canopy Growth (NYSE: CGC) , Tilray (NASDAQ: TLRY) , and Cronos Group (NASDAQ: CRON) -- which have lost a staggering amount of money, combined, on an operating basis. Profitability may be around the corner for Canada's big... | This is especially true of the four most popular marijuana stocks -- Aurora Cannabis (NYSE: ACB) , Canopy Growth (NYSE: CGC) , Tilray (NASDAQ: TLRY) , and Cronos Group (NASDAQ: CRON) -- which have lost a staggering amount of money, combined, on an operating basis. Profitability may be around the corner for Canada's big... |
38574.0 | 2019-03-27 00:00:00 UTC | Is the MJ ETF Worth a Look as Marijuana Stocks Rise and Fall? | ACB | https://www.nasdaq.com/articles/mj-etf-worth-look-marijuana-stocks-rise-and-fall-2019-03-27 | nan | nan | If you are interested in investing in marijuana stocks but don’t know the best way to get started, you may want to take a closer look at the ETFMG Alternative Harvest ETF (NYSEARCA:), a marijuana-themed exchange-traded fund (ETF) that has over a $1 billion in assets under management.
Source: Shutterstock
Before we disc... | Several of the major pot stocks in the MJ ETF include Aurora Cannabis, GW Pharmaceuticals (NASDAQ:), Cronos Group, Canopy Growth, Tilray and Green Organic Dutchman Holdings (OTCMKTS:) — companies that are becoming increasingly mainstream. For example, in August 2018, the alcoholic beverages giant Constellation Brands (... | This plant has different strains, one of which is “Industrial Hemp” and the other which is “Marijuana.” Therefore hemp and marijuana are sometimes referred to as ‘cousins.’ Industrial Hemp naturally has high levels of CBD and low levels of tetrahydrocannabinol (THC). In 2018, Canada legalized marijuana federally, a ste... | Source: Shutterstock Before we discuss the details and outlook of this marijuana ETF, let’s take a quick look at the legalized Marijuana Industry (MI) — a nascent but growing industry that has helped add to the popularity of marijuana stocks. This plant has different strains, one of which is “Industrial Hemp” and the o... | This plant has different strains, one of which is “Industrial Hemp” and the other which is “Marijuana.” Therefore hemp and marijuana are sometimes referred to as ‘cousins.’ Industrial Hemp naturally has high levels of CBD and low levels of tetrahydrocannabinol (THC). As such, investing in the industry through a themati... |
38575.0 | 2019-03-27 00:00:00 UTC | Things Are Just Heating up for Aurora Cannabis Stock | ACB | https://www.nasdaq.com/articles/things-are-just-heating-up-for-aurora-cannabis-stock-2019-03-27 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
For Canadian-based cannabis producer Aurora Cannabis (NYSE: ACB ), the year has gotten off to a spectacular start. Note that the shares have logged 76% increase. But then again, Aurora Cannabis stock has actually been making up for lost ground. Keep in mind... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips For Canadian-based cannabis producer Aurora Cannabis (NYSE: ACB ), the year has gotten off to a spectacular start. A Closer Look at Aurora Cannabis First of all, ACB stock is getting a nice boost from the legalization of recreational marijuana in Canada. AC... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips For Canadian-based cannabis producer Aurora Cannabis (NYSE: ACB ), the year has gotten off to a spectacular start. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. A Closer... | InvestorPlace - Stock Market News, Stock Advice & Trading Tips For Canadian-based cannabis producer Aurora Cannabis (NYSE: ACB ), the year has gotten off to a spectacular start. A Closer Look at Aurora Cannabis First of all, ACB stock is getting a nice boost from the legalization of recreational marijuana in Canada. AC... | As for ACB, it has been focusing on its CBD business. InvestorPlace - Stock Market News, Stock Advice & Trading Tips For Canadian-based cannabis producer Aurora Cannabis (NYSE: ACB ), the year has gotten off to a spectacular start. A Closer Look at Aurora Cannabis First of all, ACB stock is getting a nice boost from th... |
38576.0 | 2019-03-27 00:00:00 UTC | Things Are Just Heating Up for Aurora Cannabis Stock | ACB | https://www.nasdaq.com/articles/things-are-just-heating-aurora-cannabis-stock-2019-03-27 | nan | nan | For Canadian-based cannabis producer Aurora Cannabis (NYSE:), the year has gotten off to a spectacular start. Note that the shares have logged 76% increase. But then again, Aurora Cannabis stock has actually been making up for lost ground. Keep in mind that it still hasn’t reached the highs achieved back in October.
So... | I also believe that Canadian licensed producers, and Aurora in particular, are well positioned to lead in the development of the international cannabis industry as regulations evolve, with a strong, globally replicable operating model.” But Peltz will be instrumental in guiding the strategy of ACB and should be essenti... | A Closer Look at Aurora Cannabis First of all, ACB stock is getting a nice boost from the legalization of recreational marijuana in Canada. ACB also has continued to invest heavily in its drug pipeline. As for ACB, it has been focusing on its CBD business. | I also believe that Canadian licensed producers, and Aurora in particular, are well positioned to lead in the development of the international cannabis industry as regulations evolve, with a strong, globally replicable operating model.” But Peltz will be instrumental in guiding the strategy of ACB and should be essenti... | As for ACB, it has been focusing on its CBD business. A Closer Look at Aurora Cannabis First of all, ACB stock is getting a nice boost from the legalization of recreational marijuana in Canada. ACB also has continued to invest heavily in its drug pipeline. |
38577.0 | 2019-03-26 00:00:00 UTC | How Did Cronos Group Stack Up to the Competition? | ACB | https://www.nasdaq.com/articles/how-did-cronos-group-stack-competition-2019-03-26 | nan | nan | Cronos Group (NASDAQ: CRON) recently became the last of the big Canadian cannabis producers to repor t earnings for the fourth quarter of 2019. Just like its larger peers, revenue soared, and so did losses.
You might remember that 17 days into the fourth quarter, Canada began allowing Cronos, and its peers Canopy Growt... | You might remember that 17 days into the fourth quarter, Canada began allowing Cronos, and its peers Canopy Growth (NYSE: CGC) , Aurora Cannabis (NYSE: ACB) , and Tilray (NASDAQ: TLRY) , to sell recreational marijuana. Before adjusting for the fair value of growing crops, Aurora Cannabis reported a cost of goods sold t... | You might remember that 17 days into the fourth quarter, Canada began allowing Cronos, and its peers Canopy Growth (NYSE: CGC) , Aurora Cannabis (NYSE: ACB) , and Tilray (NASDAQ: TLRY) , to sell recreational marijuana. Before adjusting for the fair value of growing crops, Aurora Cannabis reported a cost of goods sold t... | You might remember that 17 days into the fourth quarter, Canada began allowing Cronos, and its peers Canopy Growth (NYSE: CGC) , Aurora Cannabis (NYSE: ACB) , and Tilray (NASDAQ: TLRY) , to sell recreational marijuana. Cronos group finished second after reporting that its cost of goods sold reached 56% of revenue durin... | You might remember that 17 days into the fourth quarter, Canada began allowing Cronos, and its peers Canopy Growth (NYSE: CGC) , Aurora Cannabis (NYSE: ACB) , and Tilray (NASDAQ: TLRY) , to sell recreational marijuana. Tilray doesn't separate fair value adjustments from production costs, which could explain why the com... |
38578.0 | 2019-03-26 00:00:00 UTC | Say What? Marijuana Sales Fell Almost 5% in Canada in January | ACB | https://www.nasdaq.com/articles/say-what-marijuana-sales-fell-almost-5-canada-january-2019-03-26 | nan | nan | For opportunistic and growth-oriented investors, the legalization of marijuana in Canada is the greatest thing since sliced bread. It gives investors the opportunity to get in on the ground floor, so to speak, of an industry with multibillion-dollar potential.
For added context, a report released earlier this year by A... | On the other hand, this lull in sales growth is a bit worrisome for Aurora Cannabis (NYSE: ACB) , which, in its October-through-December quarter, supplied about 20% of the marijuana purchased throughout Canada. For added context, a report released earlier this year by Arcview Market Research and BDS Analytics calls for... | On the other hand, this lull in sales growth is a bit worrisome for Aurora Cannabis (NYSE: ACB) , which, in its October-through-December quarter, supplied about 20% of the marijuana purchased throughout Canada. However, recently released sales data from Canada appears to show that the initial buzz of recreational weed ... | On the other hand, this lull in sales growth is a bit worrisome for Aurora Cannabis (NYSE: ACB) , which, in its October-through-December quarter, supplied about 20% of the marijuana purchased throughout Canada. Canada's recreational buzz is fading According to the monthly published retail trade sales data by Statistics... | On the other hand, this lull in sales growth is a bit worrisome for Aurora Cannabis (NYSE: ACB) , which, in its October-through-December quarter, supplied about 20% of the marijuana purchased throughout Canada. Expected to generate up to $6 billion in sales for Canada by 2022, recreational weed sales are on pace for le... |
38579.0 | 2019-03-26 00:00:00 UTC | 10 Things You'll Want to Know About Europe's Fast-Growing Marijuana Market | ACB | https://www.nasdaq.com/articles/10-things-youll-want-know-about-europes-fast-growing-marijuana-market-2019-03-26 | nan | nan | You've probably heard plenty about the launch of the Canadian recreational marijuana market. And you are likely up to speed on the rapid expansion of legalization of both medical and recreational marijuana in the U.S. But how much do you know about marijuana markets in Europe?
Cannabis market research company Brightfie... | Several top Canadian marijuana producers supply products to the German market, including Aurora Cannabis (NYSE: ACB) , Canopy Growth (NYSE: CGC) , and Tilray (NASDAQ: TLRY) . The CBD market "has gotten a significantly stronger foothold across European states than has medical cannabis," according to the Brightfield Grou... | Several top Canadian marijuana producers supply products to the German market, including Aurora Cannabis (NYSE: ACB) , Canopy Growth (NYSE: CGC) , and Tilray (NASDAQ: TLRY) . European medical cannabis market projected to grow to nearly $8 billion by 2023 Brightfield Group estimates that Europe's legal medical cannabis ... | Several top Canadian marijuana producers supply products to the German market, including Aurora Cannabis (NYSE: ACB) , Canopy Growth (NYSE: CGC) , and Tilray (NASDAQ: TLRY) . European medical cannabis market projected to grow to nearly $8 billion by 2023 Brightfield Group estimates that Europe's legal medical cannabis ... | Several top Canadian marijuana producers supply products to the German market, including Aurora Cannabis (NYSE: ACB) , Canopy Growth (NYSE: CGC) , and Tilray (NASDAQ: TLRY) . But how much do you know about marijuana markets in Europe? European medical cannabis market projected to grow to nearly $8 billion by 2023 Brigh... |
38580.0 | 2019-03-26 00:00:00 UTC | Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know | ACB | https://www.nasdaq.com/articles/aurora-cannabis-inc.-acb-stock-sinks-as-market-gains%3A-what-you-should-know-2019-03-26 | nan | nan | Aurora Cannabis Inc. (ACB) closed the most recent trading day at $9.15, moving -1.05% from the previous trading session. This change lagged the S&P 500's daily gain of 0.72%. Elsewhere, the Dow gained 0.55%, while the tech-heavy Nasdaq added 0.71%.
Prior to today's trading, shares of the company had gained 26.89% over ... | Aurora Cannabis Inc. (ACB) closed the most recent trading day at $9.15, moving -1.05% from the previous trading session. Wall Street will be looking for positivity from ACB as it approaches its nex t earnings report date. It is also important to note the recent changes to analyst estimates for ACB. | Click to get this free report Aurora Cannabis Inc. (ACB): Free Stock Analysis Report To read this article on Zacks.com click here. Aurora Cannabis Inc. (ACB) closed the most recent trading day at $9.15, moving -1.05% from the previous trading session. Wall Street will be looking for positivity from ACB as it approaches... | Aurora Cannabis Inc. (ACB) closed the most recent trading day at $9.15, moving -1.05% from the previous trading session. Wall Street will be looking for positivity from ACB as it approaches its nex t earnings report date. It is also important to note the recent changes to analyst estimates for ACB. | Aurora Cannabis Inc. (ACB) closed the most recent trading day at $9.15, moving -1.05% from the previous trading session. Wall Street will be looking for positivity from ACB as it approaches its nex t earnings report date. It is also important to note the recent changes to analyst estimates for ACB. |
38581.0 | 2019-03-25 00:00:00 UTC | Analyst’s Top 3 Cannabis Stocks Are Not What You Think | ACB | https://www.nasdaq.com/articles/analysts-top-3-cannabis-stocks-are-not-what-you-think-2019-03-25 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Cannabis stocks have gotten a lot of attention on Wall Street in the past year after a handful of popular Canadian growers started hitting the U.S. markets. U.S.-listed names like Canopy Growth Corp (NYSE: CGC ), Tilray (NASDAQ: TLRY ) and Aurora Cannabis (... | U.S.-listed names like Canopy Growth Corp (NYSE: CGC ), Tilray (NASDAQ: TLRY ) and Aurora Cannabis (NYSE: ACB ) get get most of the publicity. "In our view, the most promising public companies - i.e., those whose stocks possess the most attractive risk/reward profiles - are the U.S.-based MSOs - which are assembling do... | U.S.-listed names like Canopy Growth Corp (NYSE: CGC ), Tilray (NASDAQ: TLRY ) and Aurora Cannabis (NYSE: ACB ) get get most of the publicity. Source: Shutterstock However, OTC-traded stocks Curaleaf Holdings (OTC: CURL ), Medmen Enterprises (OTC: MMNFF ) and Green Thumb Industries (OTC: GTBIF ) could be the best canna... | U.S.-listed names like Canopy Growth Corp (NYSE: CGC ), Tilray (NASDAQ: TLRY ) and Aurora Cannabis (NYSE: ACB ) get get most of the publicity. InvestorPlace - Stock Market News, Stock Advice & Trading Tips Cannabis stocks have gotten a lot of attention on Wall Street in the past year after a handful of popular Canadian... | U.S.-listed names like Canopy Growth Corp (NYSE: CGC ), Tilray (NASDAQ: TLRY ) and Aurora Cannabis (NYSE: ACB ) get get most of the publicity. Ultimately, federal legalization will expand that market to at least $59 billion in size, Fortune says. As of early 2019, the top 10 MSOs had a combined market capitalization of... |
38582.0 | 2019-03-25 00:00:00 UTC | 3 Things to Watch for Cronos Group Stock Ahead of Earnings | ACB | https://www.nasdaq.com/articles/3-things-watch-cronos-group-stock-ahead-earnings-2019-03-25 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
I can't think of a more exciting sector than legal marijuana. But like every industry, a fresh response is necessary following the honeymoon phase. For Cronos Group (NASDAQ: CRON ), the company faces a critical earnings report for its fourth quarter. Althou... | For example, consider the hoopla surrounding Aurora Cannabis ' (NYSE: ACB ) acquisition of Whistler Medical Marijuana. Considering that technical momentum has dried up for nearly two months, and that analysts are skeptical of the sector's production capabilities, it's critical that CRON delivers the goods. Wall Street ... | For example, consider the hoopla surrounding Aurora Cannabis ' (NYSE: ACB ) acquisition of Whistler Medical Marijuana. 7 Reasons Why Apple Streaming Won't Move the Needle for Apple Stock Of course, with such a dynamic industry, investors should be prepared for anything. Here are three key considerations for CRON stock ... | For example, consider the hoopla surrounding Aurora Cannabis ' (NYSE: ACB ) acquisition of Whistler Medical Marijuana. InvestorPlace - Stock Market News, Stock Advice & Trading Tips I can't think of a more exciting sector than legal marijuana. Here are three key considerations for CRON stock ahead of its anticipated Q4... | For example, consider the hoopla surrounding Aurora Cannabis ' (NYSE: ACB ) acquisition of Whistler Medical Marijuana. For Cronos Group (NASDAQ: CRON ), the company faces a critical earnings report for its fourth quarter. Here are three key considerations for CRON stock ahead of its anticipated Q4 earnings release: Rev... |
38583.0 | 2019-03-25 00:00:00 UTC | Pre-Market Most Active for Mar 25, 2019 : SQQQ, QQQ, UBS, AMD, NOK, PTI, IDTI, TVIX, STM, ACB, PG, AEG | ACB | https://www.nasdaq.com/articles/pre-market-most-active-mar-25-2019-sqqq-qqq-ubs-amd-nok-pti-idti-tvix-stm-acb-pg-aeg-2019 | nan | nan | The NASDAQ 100 Pre-Market Indicator is down -7.88 to 7,318.18. The total Pre-Market volume is currently 6,042,457 shares traded.
The following are the most active stocks for the pre-market session :
ProShares UltraPro Short QQQ ( SQQQ ) is +0.07 at $10.43, with 930,361 shares traded. This represents a 7.86% increase fr... | Aurora Cannabis Inc. ( ACB ) is -0.08 at $8.95, with 188,604 shares traded. ACB's current last sale is 101.88% of the target price of $8.785. The following are the most active stocks for the pre-market session : ProShares UltraPro Short QQQ ( SQQQ ) is +0.07 at $10.43, with 930,361 shares traded. | Aurora Cannabis Inc. ( ACB ) is -0.08 at $8.95, with 188,604 shares traded. ACB's current last sale is 101.88% of the target price of $8.785. The total Pre-Market volume is currently 6,042,457 shares traded. | Aurora Cannabis Inc. ( ACB ) is -0.08 at $8.95, with 188,604 shares traded. ACB's current last sale is 101.88% of the target price of $8.785. The total Pre-Market volume is currently 6,042,457 shares traded. | Aurora Cannabis Inc. ( ACB ) is -0.08 at $8.95, with 188,604 shares traded. ACB's current last sale is 101.88% of the target price of $8.785. The following are the most active stocks for the pre-market session : ProShares UltraPro Short QQQ ( SQQQ ) is +0.07 at $10.43, with 930,361 shares traded. |
38584.0 | 2019-03-24 00:00:00 UTC | 1 Figure That Guarantees a Canadian Marijuana Oversupply Is Imminent | ACB | https://www.nasdaq.com/articles/1-figure-guarantees-canadian-marijuana-oversupply-imminent-2019-03-24 | nan | nan | The legal marijuana industry has come an exceptionally long way in a very short period. As recently as 2005, recreational cannabis was illegal everywhere, just a small handful of U.S. states were allowing medical marijuana to be prescribed by a physician, and a Gallup survey found that just one out of three Americans s... | Aurora Cannabis (NYSE: ACB) , which projects to be the largest producer by peak annual yield at 700,000 kilos, has cemented its presence via distribution or cultivation deals in 24 countries , including Canada, Having these overseas sales channels available will allow Aurora Cannabis to move product outside of Canada a... | Aurora Cannabis (NYSE: ACB) , which projects to be the largest producer by peak annual yield at 700,000 kilos, has cemented its presence via distribution or cultivation deals in 24 countries , including Canada, Having these overseas sales channels available will allow Aurora Cannabis to move product outside of Canada a... | Aurora Cannabis (NYSE: ACB) , which projects to be the largest producer by peak annual yield at 700,000 kilos, has cemented its presence via distribution or cultivation deals in 24 countries , including Canada, Having these overseas sales channels available will allow Aurora Cannabis to move product outside of Canada a... | Aurora Cannabis (NYSE: ACB) , which projects to be the largest producer by peak annual yield at 700,000 kilos, has cemented its presence via distribution or cultivation deals in 24 countries , including Canada, Having these overseas sales channels available will allow Aurora Cannabis to move product outside of Canada a... |
38585.0 | 2019-03-24 00:00:00 UTC | Better Buy: Aurora Cannabis vs. Constellation Brands | ACB | https://www.nasdaq.com/articles/better-buy-aurora-cannabis-vs-constellation-brands-2019-03-24 | nan | nan | There's a pretty good chance that 10 years from now Aurora Cannabis (NYSE: ACB) and/or Constellation Brands (NYSE: STZ) will be worth a lot more, thanks to growth in the global cannabis market. Aurora is already a top marijuana stock. Alcoholic beverage maker Constellation is sort of a marijuana stock as well by virtue... | There's a pretty good chance that 10 years from now Aurora Cannabis (NYSE: ACB) and/or Constellation Brands (NYSE: STZ) will be worth a lot more, thanks to growth in the global cannabis market. Alcoholic beverage maker Constellation is sort of a marijuana stock as well by virtue of its 35% stake in Canopy Growth (NYSE:... | There's a pretty good chance that 10 years from now Aurora Cannabis (NYSE: ACB) and/or Constellation Brands (NYSE: STZ) will be worth a lot more, thanks to growth in the global cannabis market. Second, the primary keys to success in the cannabis market are capacity, distribution channels, and low operating costs. In th... | There's a pretty good chance that 10 years from now Aurora Cannabis (NYSE: ACB) and/or Constellation Brands (NYSE: STZ) will be worth a lot more, thanks to growth in the global cannabis market. The case for Constellation Brands With Constellation Brands, investors must look at the company's opportunities in its core bu... | There's a pretty good chance that 10 years from now Aurora Cannabis (NYSE: ACB) and/or Constellation Brands (NYSE: STZ) will be worth a lot more, thanks to growth in the global cannabis market. Aurora's operating cost structure isn't leading the industry right now. The case for Constellation Brands With Constellation B... |
38586.0 | 2019-03-24 00:00:00 UTC | Don't Laugh: Aurora Cannabis, Canopy Growth, and Tilray Could Be Big-Time Bargains | ACB | https://www.nasdaq.com/articles/dont-laugh-aurora-cannabis-canopy-growth-and-tilray-could-be-big-time-bargains-2019-03-24 | nan | nan | Aurora Cannabis (NYSE: ACB) , Canopy Growth (NYSE: CGC) , and Tilray (NASDAQ: TLRY) combined made less than $150 million in the last quarter, yet all three marijuana stocks have market caps of at least $6.7 billion, with Canopy's market cap a whopping $16 billion. We're talking about stratospheric price-to-sales (P/S) ... | Aurora Cannabis (NYSE: ACB) , Canopy Growth (NYSE: CGC) , and Tilray (NASDAQ: TLRY) combined made less than $150 million in the last quarter, yet all three marijuana stocks have market caps of at least $6.7 billion, with Canopy's market cap a whopping $16 billion. Tilray CEO Brendan Kennedy said in his company's Q4 con... | Aurora Cannabis (NYSE: ACB) , Canopy Growth (NYSE: CGC) , and Tilray (NASDAQ: TLRY) combined made less than $150 million in the last quarter, yet all three marijuana stocks have market caps of at least $6.7 billion, with Canopy's market cap a whopping $16 billion. Although Aurora, Canopy, and Tilray can't enter the U.S... | Aurora Cannabis (NYSE: ACB) , Canopy Growth (NYSE: CGC) , and Tilray (NASDAQ: TLRY) combined made less than $150 million in the last quarter, yet all three marijuana stocks have market caps of at least $6.7 billion, with Canopy's market cap a whopping $16 billion. Arguments for Aurora, Canopy, and Tilray Based on all o... | Aurora Cannabis (NYSE: ACB) , Canopy Growth (NYSE: CGC) , and Tilray (NASDAQ: TLRY) combined made less than $150 million in the last quarter, yet all three marijuana stocks have market caps of at least $6.7 billion, with Canopy's market cap a whopping $16 billion. A view on valuation I don't think any stock, regardless... |
38587.0 | 2019-03-23 00:00:00 UTC | The Most Compelling Argument Why Tilray Is a Better Buy Than Aurora Cannabis and Canopy Growth | ACB | https://www.nasdaq.com/articles/most-compelling-argument-why-tilray-better-buy-aurora-cannabis-and-canopy-growth-2019-03 | nan | nan | Let me first state unequivocally that I have in no way been a big fan of Tilray (NASDAQ: TLRY) . Last November, I called Tilray the most dangerous big marijuana stock on the market . I didn't like the company's lack of transparency in its fourth-quarter update last week, with Tilray not disclosing metrics that most of ... | They do this despite most analysts choosing Aurora Cannabis (NYSE: ACB) or Canopy Growth (NYSE: CGC) as better picks. I didn't like the company's lack of transparency in its fourth-quarter update last week, with Tilray not disclosing metrics that most of its peers make readily available. But there's one thing that Tilr... | They do this despite most analysts choosing Aurora Cannabis (NYSE: ACB) or Canopy Growth (NYSE: CGC) as better picks. Sure, Canopy Growth landed the most important deal so far for marijuana producers by teaming up with alcoholic beverage maker Constellation Brands . Tilray first teamed up with Novartis ' Sandoz unit to... | They do this despite most analysts choosing Aurora Cannabis (NYSE: ACB) or Canopy Growth (NYSE: CGC) as better picks. Tilray's deals with big players outside of the cannabis industry haven't involved significant investments by those companies in Tilray. If the company can successfully execute on its strategy, Tilray co... | They do this despite most analysts choosing Aurora Cannabis (NYSE: ACB) or Canopy Growth (NYSE: CGC) as better picks. Then there's Tilray. So is Tilray actually a better buy than Aurora Cannabis or Canopy Growth? |
38588.0 | 2019-03-23 00:00:00 UTC | Don't Make This Simple Marijuana Investing Mistake | ACB | https://www.nasdaq.com/articles/dont-make-simple-marijuana-investing-mistake-2019-03-23 | nan | nan | To say that the marijuana industry is flowering would be an understatement of epic proportions. In just a few years, the legal weed industry has exploded, with global sales expected to more than triple from a reported $5.4 billion in 2015, per Arcview Market Research and BDS Analytics, to an estimated $16.9 billion in ... | There's more to investing than just share price For example, both Auxly Cannabis Group (NASDAQOTH: CBWTF) and Aurora Cannabis (NYSE: ACB) are two popular plays in the marijuana industry. This rapid sales growth, and the relatively steady popularity and growing acceptance of cannabis as a mainstream product, is what's d... | There's more to investing than just share price For example, both Auxly Cannabis Group (NASDAQOTH: CBWTF) and Aurora Cannabis (NYSE: ACB) are two popular plays in the marijuana industry. However, relying solely on share price while paying little mind to market cap (i.e., share price multiplied by outstanding shares) or... | There's more to investing than just share price For example, both Auxly Cannabis Group (NASDAQOTH: CBWTF) and Aurora Cannabis (NYSE: ACB) are two popular plays in the marijuana industry. This investor thesis is based on the (incorrect) idea that owning more shares of stock (i.e., buying hundreds or thousands of shares ... | There's more to investing than just share price For example, both Auxly Cannabis Group (NASDAQOTH: CBWTF) and Aurora Cannabis (NYSE: ACB) are two popular plays in the marijuana industry. As a result, and following the closure of a few recent deals, the company has issued 1 billion shares in less than five years and has... |
38589.0 | 2019-03-23 00:00:00 UTC | The STATES Act: What It Means for Marijuana Stocks | ACB | https://www.nasdaq.com/articles/states-act-what-it-means-marijuana-stocks-2019-03-23 | nan | nan | Marijuana stocks have been on fire lately, but many investors understand all too well that so far, cannabis producers have only tapped into a tiny part of the potential market for their products. That's because despite efforts at the state level to legalize pot, marijuana remains illegal under U.S. federal law.
Lawmake... | That in turn would lead to a massive stampede among established Canadian marijuana stocks like Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB) , as well as new business operations domestically to see which could most quickly serve a massive, newly opened market for their products. If it gets passed, the STATE... | That in turn would lead to a massive stampede among established Canadian marijuana stocks like Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB) , as well as new business operations domestically to see which could most quickly serve a massive, newly opened market for their products. In other words, there would ... | That in turn would lead to a massive stampede among established Canadian marijuana stocks like Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB) , as well as new business operations domestically to see which could most quickly serve a massive, newly opened market for their products. The Strengthening the Tenth ... | That in turn would lead to a massive stampede among established Canadian marijuana stocks like Canopy Growth (NYSE: CGC) and Aurora Cannabis (NYSE: ACB) , as well as new business operations domestically to see which could most quickly serve a massive, newly opened market for their products. The Strengthening the Tenth ... |
38590.0 | 2019-03-22 00:00:00 UTC | 7 Marijuana Stocks to Play the CBD Trend | ACB | https://www.nasdaq.com/articles/7-marijuana-stocks-to-play-the-cbd-trend-2019-03-22 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Cannabidiol (CBD) is emerging as a red-hot category of the marijuana industry. CBD includes compounds in the cannabis sativa plant that do not produce a high. In fact, over the years, CBDs have been shown to have powerful therapeutic effects.
Now it looks l... | Aurora Cannabis (ACB) Aurora Cannabis (NYSE: ACB ), a Canadian based cannabis producer, has been building up its CBD business. Next, ACB has been focused on revving up its product offerings. What's more, ACB has been aggressive with its dealmaking. | Aurora Cannabis (ACB) Aurora Cannabis (NYSE: ACB ), a Canadian based cannabis producer, has been building up its CBD business. Next, ACB has been focused on revving up its product offerings. What's more, ACB has been aggressive with its dealmaking. | Aurora Cannabis (ACB) Aurora Cannabis (NYSE: ACB ), a Canadian based cannabis producer, has been building up its CBD business. Next, ACB has been focused on revving up its product offerings. What's more, ACB has been aggressive with its dealmaking. | Aurora Cannabis (ACB) Aurora Cannabis (NYSE: ACB ), a Canadian based cannabis producer, has been building up its CBD business. Next, ACB has been focused on revving up its product offerings. What's more, ACB has been aggressive with its dealmaking. |
38591.0 | 2019-03-22 00:00:00 UTC | Pre-Market Most Active for Mar 22, 2019 : NOK, IMMP, SQQQ, AMD, CHGG, AVP, TVIX, QQQ, ACB, TQQQ, BAC, NKE | ACB | https://www.nasdaq.com/articles/pre-market-most-active-mar-22-2019-nok-immp-sqqq-amd-chgg-avp-tvix-qqq-acb-tqqq-bac-nke | nan | nan | The NASDAQ 100 Pre-Market Indicator is down -23.71 to 7,469.56. The total Pre-Market volume is currently 8,105,023 shares traded.
The following are the most active stocks for the pre-market session :
Nokia Corporation ( NOK ) is -0.37 at $5.89, with 3,416,626 shares traded. As reported by Zacks, the current mean recomm... | Aurora Cannabis Inc. ( ACB ) is -0.16 at $9.41, with 314,956 shares traded. ACB's current last sale is 107.11% of the target price of $8.785. The following are the most active stocks for the pre-market session : Nokia Corporation ( NOK ) is -0.37 at $5.89, with 3,416,626 shares traded. | The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Aurora Cannabis Inc. ( ACB ) is -0.16 at $9.41, with 314,956 shares traded. ACB's current last sale is 107.11% of the target price of $8.785. | Aurora Cannabis Inc. ( ACB ) is -0.16 at $9.41, with 314,956 shares traded. ACB's current last sale is 107.11% of the target price of $8.785. The following are the most active stocks for the pre-market session : Nokia Corporation ( NOK ) is -0.37 at $5.89, with 3,416,626 shares traded. | Aurora Cannabis Inc. ( ACB ) is -0.16 at $9.41, with 314,956 shares traded. ACB's current last sale is 107.11% of the target price of $8.785. The NASDAQ 100 Pre-Market Indicator is down -23.71 to 7,469.56. |
38592.0 | 2019-03-21 00:00:00 UTC | Tilray Should Make This Shocking Business Move Before It's Too Late | ACB | https://www.nasdaq.com/articles/tilray-should-make-shocking-business-move-its-too-late-2019-03-21 | nan | nan | Strategic mergers and acquisitions (M&A) are commonplace in the corporate world for a number of solid reasons. Most commonly, two top companies in their respective field agree to join forces via a merger to rapidly expand their customer base and create positive synergies and cost savings across the supply chain.
Over t... | The company also hopes to make additional inroads into various international markets, and essentially let Canopy Growth Corporation (NYSE: CGC) and Aurora Cannabis (NYSE: ACB) dominate the highly competitive Canadian recreational market. Most commonly, two top companies in their respective field agree to join forces vi... | The company also hopes to make additional inroads into various international markets, and essentially let Canopy Growth Corporation (NYSE: CGC) and Aurora Cannabis (NYSE: ACB) dominate the highly competitive Canadian recreational market. The Motley Fool owns shares of and recommends GlaxoSmithKline. The Motley Fool rec... | The company also hopes to make additional inroads into various international markets, and essentially let Canopy Growth Corporation (NYSE: CGC) and Aurora Cannabis (NYSE: ACB) dominate the highly competitive Canadian recreational market. While this key financial metric should drop to a more reasonable 40 this year and ... | The company also hopes to make additional inroads into various international markets, and essentially let Canopy Growth Corporation (NYSE: CGC) and Aurora Cannabis (NYSE: ACB) dominate the highly competitive Canadian recreational market. In 1999, Pfizer agreed to a $90.2 billion deal with Warner-Lambert to form one of ... |
38593.0 | 2019-03-21 00:00:00 UTC | The 1 Surprising Result in Canada's Latest National Cannabis Survey | ACB | https://www.nasdaq.com/articles/1-surprising-result-canadas-latest-national-cannabis-survey-2019-03-21 | nan | nan | Last year was a breakthrough year for the legal cannabis industry. Having long been viewed as taboo, the passage of the Cannabis Act in June in our neighbor to the north, and the official legalization and sale of recreational marijuana in licensed dispensaries and online stores as of Oct. 17, 2018, in Canada, validated... | On one hand, Aurora Cannabis (NYSE: ACB) , the projected largest producer with perhaps up to 700,000 kilos in peak annual production, is expected to focus on medical marijuana patients. Having long been viewed as taboo, the passage of the Cannabis Act in June in our neighbor to the north, and the official legalization ... | On one hand, Aurora Cannabis (NYSE: ACB) , the projected largest producer with perhaps up to 700,000 kilos in peak annual production, is expected to focus on medical marijuana patients. Of the respondents aged 15 and older who used cannabis in the past three months, 7% reported using weed solely for recreational purpos... | On one hand, Aurora Cannabis (NYSE: ACB) , the projected largest producer with perhaps up to 700,000 kilos in peak annual production, is expected to focus on medical marijuana patients. Of the respondents aged 15 and older who used cannabis in the past three months, 7% reported using weed solely for recreational purpos... | On one hand, Aurora Cannabis (NYSE: ACB) , the projected largest producer with perhaps up to 700,000 kilos in peak annual production, is expected to focus on medical marijuana patients. If you think you know Canada's marijuana industry, think again Every three months, Statistics Canada releases the results of its Natio... |
38594.0 | 2019-03-21 00:00:00 UTC | Pre-Market Most Active for Mar 21, 2019 : BIIB, MU, SQQQ, QQQ, NOK, EQH, OPK, ERIC, CHL, LYG, CAG, ACB | ACB | https://www.nasdaq.com/articles/pre-market-most-active-mar-21-2019-biib-mu-sqqq-qqq-nok-eqh-opk-eric-chl-lyg-cag-acb-2019 | nan | nan | The NASDAQ 100 Pre-Market Indicator is down -24.8 to 7,355.95. The total Pre-Market volume is currently 8,846,855 shares traded.
The following are the most active stocks for the pre-market session :
Biogen Inc. ( BIIB ) is -83.12 at $237.47, with 1,194,243 shares traded. As reported by Zacks, the current mean recommend... | Reuters Reports: Conagra tops profit estimates on price-hike boost Aurora Cannabis Inc. ( ACB ) is -0.1 at $9.71, with 195,459 shares traded. ACB's current last sale is 110.53% of the target price of $8.785. As reported in the last short interest update the days to cover for OPK is 12.087305; this calculation is based ... | Reuters Reports: Conagra tops profit estimates on price-hike boost Aurora Cannabis Inc. ( ACB ) is -0.1 at $9.71, with 195,459 shares traded. ACB's current last sale is 110.53% of the target price of $8.785. The total Pre-Market volume is currently 8,846,855 shares traded. | Reuters Reports: Conagra tops profit estimates on price-hike boost Aurora Cannabis Inc. ( ACB ) is -0.1 at $9.71, with 195,459 shares traded. ACB's current last sale is 110.53% of the target price of $8.785. The following are the most active stocks for the pre-market session : Biogen Inc. ( BIIB ) is -83.12 at $237.47,... | Reuters Reports: Conagra tops profit estimates on price-hike boost Aurora Cannabis Inc. ( ACB ) is -0.1 at $9.71, with 195,459 shares traded. ACB's current last sale is 110.53% of the target price of $8.785. The following are the most active stocks for the pre-market session : Biogen Inc. ( BIIB ) is -83.12 at $237.47,... |
38595.0 | 2019-03-21 00:00:00 UTC | 3 Medical Marijuana Stocks to Buy | ACB | https://www.nasdaq.com/articles/3-medical-marijuana-stocks-to-buy-2019-03-21 | nan | nan | InvestorPlace - Stock Market News, Stock Advice & Trading Tips
[Editor's note: This story was previously published in February 2018. It has since been updated and republished. ]
Often, when analysts or bloggers talk up the potential of marijuana stocks , the focus is on the consumer side of the industry. But some of th... | Admittedly, uplisting hasn't helped pot stocks in and of itself ( most notablyAurora Cannabis (NYSE: ACB ) took a lot longer to take off than was expected), but it certainly didn't hurt. The combination of Altria's advertising and distribution reach and Cronos' production capabilities would seem best fit for the consum... | Admittedly, uplisting hasn't helped pot stocks in and of itself ( most notablyAurora Cannabis (NYSE: ACB ) took a lot longer to take off than was expected), but it certainly didn't hurt. Source: Shutterstock Charlotte's Web (CWBHF) Charlotte's Web (OTCMKTS: CWBHF ) has become one of the leading players in CBD oil (cann... | Admittedly, uplisting hasn't helped pot stocks in and of itself ( most notablyAurora Cannabis (NYSE: ACB ) took a lot longer to take off than was expected), but it certainly didn't hurt. But some of the best stocks in the pot sector may be medical marijuana stocks. But for investors who see medical marijuana stocks as ... | Admittedly, uplisting hasn't helped pot stocks in and of itself ( most notablyAurora Cannabis (NYSE: ACB ) took a lot longer to take off than was expected), but it certainly didn't hurt. But some of the best stocks in the pot sector may be medical marijuana stocks. InvestorPlace's Matt McCall named CWBHF (the stock als... |
38596.0 | 2019-03-20 00:00:00 UTC | Pre-Market Most Active for Mar 20, 2019 : AMD, FTCH, INVH, ACB, SQQQ, NOMD, TME, CHK, ERIC, DERM, QQQ, MU | ACB | https://www.nasdaq.com/articles/pre-market-most-active-mar-20-2019-amd-ftch-invh-acb-sqqq-nomd-tme-chk-eric-derm-qqq-mu | nan | nan | The NASDAQ 100 Pre-Market Indicator is up .29 to 7,349.57. The total Pre-Market volume is currently 4,618,680 shares traded.
The following are the most active stocks for the pre-market session :
Advanced Micro Devices, Inc. ( AMD ) is +0.51 at $26.51, with 1,557,011 shares traded. AMD's current last sale is 94.68% of t... | Aurora Cannabis Inc. ( ACB ) is -0.09 at $9.87, with 747,887 shares traded. ACB's current last sale is 112.35% of the target price of $8.785. The following are the most active stocks for the pre-market session : Advanced Micro Devices, Inc. ( AMD ) is +0.51 at $26.51, with 1,557,011 shares traded. | Aurora Cannabis Inc. ( ACB ) is -0.09 at $9.87, with 747,887 shares traded. ACB's current last sale is 112.35% of the target price of $8.785. As reported by Zacks, the current mean recommendation for FTCH is in the "buy range". | Aurora Cannabis Inc. ( ACB ) is -0.09 at $9.87, with 747,887 shares traded. ACB's current last sale is 112.35% of the target price of $8.785. As reported by Zacks, the current mean recommendation for INVH is in the "buy range". | Aurora Cannabis Inc. ( ACB ) is -0.09 at $9.87, with 747,887 shares traded. ACB's current last sale is 112.35% of the target price of $8.785. As reported by Zacks, the current mean recommendation for INVH is in the "buy range". |
38597.0 | 2019-03-20 00:00:00 UTC | Tilray: No Sane Investor Can Justify Its $7 Billion Valuation Following Its Fourth-Quarter Results | ACB | https://www.nasdaq.com/articles/tilray-no-sane-investor-can-justify-its-7-billion-valuation-following-its-fourth-quarter | nan | nan | On Monday, following the closing bell, Canadian cannabis grower Tilray (NASDAQ: TLRY) released its much-anticipated fourth-quarter and full-year operating results.
With Canada officially legalizing recreational marijuana on Oct. 17, 2018, Wall Street and investors were expecting pretty much the same story they've seen ... | Sure, this represents a threefold increase from Q4 2017 and a doubling for the full year, but it pales in comparison to the 10,102 kilograms Canopy Growth (NYSE: CGC) sold in its fiscal third quarter or the 6,999 kilograms Aurora Cannabis (NYSE: ACB) sold in its recently reported second-quarter results. With Canada off... | Sure, this represents a threefold increase from Q4 2017 and a doubling for the full year, but it pales in comparison to the 10,102 kilograms Canopy Growth (NYSE: CGC) sold in its fiscal third quarter or the 6,999 kilograms Aurora Cannabis (NYSE: ACB) sold in its recently reported second-quarter results. Thus, even with... | Sure, this represents a threefold increase from Q4 2017 and a doubling for the full year, but it pales in comparison to the 10,102 kilograms Canopy Growth (NYSE: CGC) sold in its fiscal third quarter or the 6,999 kilograms Aurora Cannabis (NYSE: ACB) sold in its recently reported second-quarter results. Tilray's fourth... | Sure, this represents a threefold increase from Q4 2017 and a doubling for the full year, but it pales in comparison to the 10,102 kilograms Canopy Growth (NYSE: CGC) sold in its fiscal third quarter or the 6,999 kilograms Aurora Cannabis (NYSE: ACB) sold in its recently reported second-quarter results. On the surface,... |
38598.0 | 2019-03-20 00:00:00 UTC | Aurora Cannabis Inc. (ACB) Dips More Than Broader Markets: What You Should Know | ACB | https://www.nasdaq.com/articles/aurora-cannabis-inc.-acb-dips-more-than-broader-markets%3A-what-you-should-know-2019-03-20 | nan | nan | In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $9.80, marking a -1.61% move from the previous day. This change lagged the S&P 500's 0.29% loss on the day. Meanwhile, the Dow lost 0.55%, and the Nasdaq, a tech-heavy index, added 0.07%.
Prior to today's trading, shares of the company had gained 43.72... | In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $9.80, marking a -1.61% move from the previous day. ACB will be looking to display strength as it nears its nex t earnings release. On that day, ACB is projected to report earnings of -$0.05 per share, which would represent a year-over-year decline of ... | In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $9.80, marking a -1.61% move from the previous day. Click to get this free report Aurora Cannabis Inc. (ACB): Free Stock Analysis Report To read this article on Zacks.com click here. ACB will be looking to display strength as it nears its nex t earning... | In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $9.80, marking a -1.61% move from the previous day. ACB will be looking to display strength as it nears its nex t earnings release. On that day, ACB is projected to report earnings of -$0.05 per share, which would represent a year-over-year decline of ... | In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $9.80, marking a -1.61% move from the previous day. On that day, ACB is projected to report earnings of -$0.05 per share, which would represent a year-over-year decline of 25%. ACB will be looking to display strength as it nears its nex t earnings rele... |
38599.0 | 2019-03-20 00:00:00 UTC | These Marijuana Stocks Have Doubled So Far in 2019 | ACB | https://www.nasdaq.com/articles/these-marijuana-stocks-have-doubled-so-far-2019-2019-03-20 | nan | nan | There's no doubt that cannabis investing has never been more popular . Many high-profile companies serving the marijuana market have posted amazing gains to start 2019, and the prospects for further growth in the budding industry are only looking brighter as the year goes on.
The race to profit from the booming marijua... | ACB data by YCharts . Aurora Cannabis Finally, industry giant Aurora Cannabis (NYSE: ACB) completes the list with gains of 101% this year. Although huge numbers of companies with exposure to cannabis have seen their stock prices soar, four stand out for having delivered a double to their shareholders in just the first ... | Aurora Cannabis Finally, industry giant Aurora Cannabis (NYSE: ACB) completes the list with gains of 101% this year. ACB data by YCharts . Cronos Group Cronos Group (NASDAQ: CRON) tops the list with a return of 107% so far in 2019. | Aurora Cannabis Finally, industry giant Aurora Cannabis (NYSE: ACB) completes the list with gains of 101% this year. ACB data by YCharts . Investors hope that means that Aurora will finally find a partner worthy of its position in the marijuana market -- and that the price it's paying Peltz in the form of stock options... | Aurora Cannabis Finally, industry giant Aurora Cannabis (NYSE: ACB) completes the list with gains of 101% this year. ACB data by YCharts . More than half of CannTrust's revenue comes from these value-added products, and if that continues, then CannTrust could use its profitability advantage to jump out in front of more... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.